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ABSTRACT 
Understanding the molecular basis of neuroplasticity is an ambition of 
neuroscience. SynGAP and nNOS are two neuronal proteins which are central regulators 
of neuroplasticity. nNOS synthesizes nitric oxide, a second messenger important for 
retrograde communication between synapses, while SynGAP stimulates the GTPase 
activity of Ras and Rap. Regulation of these enzymes is vital for synaptic homeostasis, 
but there is much to learn about the details of nNOS and SynGAP activity. In this 
dissertation I address two questions about nNOS and SynGAP structural biology: what is 
the structural basis for nNOS activation by calmodulin? How do the auxiliary domains of 
SynGAP enable RapGAP activity?  
Both nNOS and SynGAP are large proteins with modular domain organization 
and flexible linkers. These features make structural analysis by mainstay techniques such 
as NMR or X-Ray crystallography excessively difficult. Hydrogen-deuterium exchange 
mass spectrometry (HDX-MS) is well-suited for investigating the structure-activity 
relationships in proteins such as nNOS and SynGAP. Hydrogen-deuterium exchange of 
amide protons with the solvent, as measured in HDX-MS, provides a wealth of 
information on the structural dynamics of proteins. Mass spectrometry in combination 
with proteolytic digestion of samples enables assignment of those perturbation to discrete 
peptides within the protein. Using this approach, I demonstrate a role for allosteric effects 
in both activation of nNOS by calmodulin and the RapGAP function of SynGAP.  
 
CHAPTER 1.    INTRODUCTION 
Molecular Theories of Learning and Memory 
Modern biological theories of learning and memory postulate that neuroplasticity, the 
ability of neurons to break and form connections among each other, is the underlying 
mechanism behind the ability to learn and store information [1]. At the microscale, 
neuroplasticity entails that synaptic junctions between neurons undergo activation-dependent 
rearrangement. The cellular correlates to neuroplasticity are long-term potentiation (LTP) 
and long-term depression (LTD) [2,3]. LTP involves recruiting receptors to the membrane at 
synaptic junctions, enlarging synaptic compartments, or synthesizing fresh signaling 
molecules. This results in the strengthening and retention of a synapse. LTD, on the other 
hand, weakens or prunes synapses. Balancing LTP versus LTD hinges on achieving an 
activation threshold of coinciding membrane depolarization and calcium flux [4,5]. Once a 
threshold is met, signaling events within the neuron must be exquisitely regulated for proper 
growth, or removal, of a synapse. It is worth noting that pyramidal neurons from the CA1 
region of the hippocampus serve as the model system for studying LTP/LTD. One of the 
most important super-complexes for integrating signals in this model is the post-synaptic 
density (PSD). 
 
Organization of the PSD 
The PSD is localized to the membrane of specialized compartments in neurons called 
dendritic spines [6]. Dendritic spines form small processes that branch off the main axon and 
serve as the reception site for excitatory synaptic inputs. As its namesake may indicate, the 
PSD was named because it appears as an electron dense region by electron microscopy. This 
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electron dense region can be more specifically defined as the PSD ‘core’; the center of 
signaling events within the PSD [7]. The PSD core is home to many receptors, cellular 
adhesion molecules, scaffolds, and signaling proteins such as GTPases and kinases (Figure 1) 
[6,8–11]. Key proteins include the PSD family of scaffolds (including PSD-95), calmodulin 
(CaM), Ca2+/Calmodulin-dependent protein kinase II (CaMKII), N-methyl-D-aspartate 
receptors (NMDARs) and 2-amino3-(5-methyl-3-oxo-1,2-oxazol-4-yl) propanoic acid 
receptors (AMPARs), neuronal nitric oxide synthase (nNOS), and synaptic GTPase 
activating protein (SynGAP) [6,11]. In fact, CaMKII, PSD-95, and SynGAP are found in 
significantly higher abundance than any other PSD component [6,10,12]. The PSD is framed 
near the membrane by a lattice rich in CaMKII, tubulin, actin, and PSD-95 family protein 
[9]. Subunits of NMDARs and AMPARs are bound to PSD-95, resulting in a mutual 
localization of these important receptors and the PSD [13,14].  As the PSD scaffold network 
transitions away from the membrane a second PSD layer called the PSD pallium emerges [7]. 
The pallial layers functions as a ‘reserve’ space for shuffling proteins to and from the activity 
of the PSD core while retaining them near the PSD. Organizing the PSD in such a manner is 
important for integrating a multitude of signaling inputs. 
 
Signaling Pathways in the PSD 
As mentioned previously, resolution of PSD signaling in LTP or LTD requires 
membrane depolarization and calcium influx to coincide [15,16]. At the PSD, NMDARs 
function as elegant coincidence detectors. NMDARs are ionotropic glutamate receptors made 
up of two GluN1 subunits associated with two GluN2 subunits, or a combination of GluN2 
and GluN3 subunits [17–19]. As coincidence detectors, NMDARs require ligand binding and 
postsynaptic depolarization to aid in Ca2+ signaling. The ligand, glutamate (or glycine), binds 
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to NMDARs opening a non-specific cation channel with high permeability to Ca2+. At resting 
membrane potentials, Mg2+ or Zn2+ can occupy a pocket in this channel and block cation 
influx [20,21]. AMPAR-mediated depolarization temporarily relieves this blockage. Thus, 
for efficient Ca2+ (and other cations) flow into the PSD the window of NMDAR engagement 
by glutamate and postsynaptic depolarization must coincide in a specific time frame. 
 Upon NMDAR-mediated Ca2+ influx, incoming free Ca2+ is quickly bound by nearby 
proteins [15,16]. CaM is a small Ca2+-sensor with four Ca2+-binding EF-hand motifs. Upon 
binding Ca2+, CaM can activate several proteins including, but not limited to, CaMKII, 
nNOS, adenylate cyclase, and Ras guanine nucleotide-releasing factor 1 (RasGRF1), 
initiating multiple signaling cascade (Figure 2) [15]. Perhaps chief among these Ca2+/CaM-
responsive proteins is CaMKII, which functions as a master regulator of LTP and LTD by 
phosphorylating several proteins at crucial signaling junctions, including SynGAP and nNOS 
[22–27]. Phosphorylation by CaMKII can modulate enzyme activity by eliciting a 
conformational change, or by shuffling proteins between layers of the PSD [7,22,28,29].  
AMPAR trafficking is the hallmark outcome of LTP/LTD [30]. When high frequency 
synaptic stimulation and calcium influx coincide LTP is initiating, leading to recruitment of 
AMPARs to the membrane [4,5,31–33]. However, if the frequency of stimulation and 
calcium flux do not reach a specific threshold, LTD will be elicited leading to AMPAR 
endocytosis.  AMPAR content tunes synaptic sensitivity by acting as additional Na+ 
channels, ensuring that membrane depolarization and calcium flux coincide more frequently 
to elicit LTP rather than LTD.  
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nNOS Signaling and Regulation 
nNOS signaling participates in multiple pathways related to neuroplasticity [34,35]. 
nNOS is activated by Ca2+/CaM, which ensures NO production is linked to synaptic activity. 
Unique to NO signaling is the ability of NO to freely diffuse across membranes allowing 
communication between the presynaptic and postsynaptic neurons [36]. nNOS shares an 
intimate relationship with soluble guanylate cyclase (sGC), the principal mediator of NO 
signaling [33,37,38]. NO binds to the ferrous heme cofactor in the heme-NO/O2-binding (H-
NOX) domain of sGC, activating the catalytic domain through a discrete allosteric pathway 
[39,40]. sGC converts GTP to the secondary messenger, cGMP, which informs multiple 
signaling cascades including Akt and ERK pathways. The canonical NO/sGC pathway 
involves activation of cGMP-dependent protein kinases (PKGs) [36,41]. Resolution of 
NO/sGC/PKG pathway has multiple outcomes related to neuronal survival, 
neurotransmission, and LTP/LTD [36,42,43]. 
 Tight regulation of nNOS is vital for neuronal homeostasis. For proper NO 
production electrons must be shuttled from the reductase domain of nNOS to its oxygenase 
domain [44,45]. Dysregulation of nNOS can interrupt electron transfer between domains 
causing electrons to leak, which leads to generation of reactive oxygen species and potential 
cellular damage [36,46–48]. As mentioned previously nNOS requires Ca2+/CaM for 
activation. It is believed that Ca2+/CaM binding initiates a conformational change that 
permits electron transfer between the reductase and oxygenase domain. Additional tuning of 
nNOS activity is achieved by phosphorylating key serine residues [29,49,50]. However, as I 
will discuss in chapter 2, the details of nNOS activation are quite complex and involve long-
range allosteric effects. 
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Biological Role of SynGAP 
 SynGAP is vital for brain development and synaptic plasticity. The importance of 
SynGAP is perhaps best illustrated in SynGAP-/- mice, which initially develop normally but 
die shortly after birth [51,52]. SynGAP+/- mice survive to adulthood, but display behavioral 
abnormalities relating to motivation and spatial learning [51,53,54]. SynGAP mutations have 
been implicated in clinical studies as a factor in neurological syndromes such as 
schizophrenia, severe intellectual disability, epilepsy, and autism spectrum disorder [55–61]. 
The cellular consequences of SynGAP knock downs or disfunction is partially understood. In 
cellular models of SynGAP+/- primary neurons, dendritic spines develop and expand 
aggressively [62,63]. This leads to over activity of excitatory synapses and seizure-like 
electrophysiological responses in culture neurons [62]. While it is clear that SynGAP is vital 
for neurological development, the details of how SynGAP performs its function remains a 
conundrum. 
SynGAP is thought to be a dual-specificity Ras- and RapGAP, positioning it as a 
central arbiter of synaptic signaling. siRNA studies of SynGAP in primary neurons revealed 
interference with SynGAP production lead to higher levels of ERK activation, but less P38 
activation [54,64]. This suggests SynGAP inhibits Ras/ERK signaling, but positively 
regulates Rap/P38 signaling. This has been directly contradicted by similar siRNA studies 
which report SynGAP acts through the Rap/P38 pathway, but not Ras/ERK [65,66]. Removal 
of SynGAP from the PSD core has been reported to correlate with an increase in Ras and 
Rap GTPase activity, suggesting the Ras/Rap signaling outcomes of SynGAP are context 
dependent [66,67]. Further complicating the biological function of SynGAP is that Ras and 
Rap signaling are known to intersect with both competitive and synergistic outcomes [68–
70]. For example, B-Raf is a shared Ras and Rap effector and is activated by both GTPases 
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[71,72]. Engagement of B-Raf by either Ras or Rap stimulated the ERK/MAPK pathway. 
Ras and Rap also bind C-Raf, but only Ras activates C-Raf. Rap functions as a competitive 
inhibitor of C-Raf by binding to, but not activating, C-Ray [73,74]. Given that SynGAP acts 
upstream of Raf, the question to be addressed is what factors determine substrate specificity 
for Ras or Rap? 
 
Biochemical Function of SynGAP 
Prerequisite to understanding the biological function of SynGAP is a basic 
understanding of SynGAP biochemistry. SynGAP contains a PH, C2, and RasGAP related 
domain followed by a large, putatively disordered tail containing multiple regulatory and 
protein interaction sites [75,76]. Designation of the SynGAP PH and C2 domains was based 
on loose homology to an unreported PH domain and the C2 domain of synaptotagmin (less 
than 20% similarity). However, the structure, function, and even boundary between the PH 
and C2 domain remain unknown. The RasGAP activity of SynGAP was first measured in 
vitro, followed several years later by the discover of significantly more efficient RapGAP 
activity [22,65,77]. While RasGAP activity apparently requires only the GAP domain, the C2 
domain was shown to be required for RapGAP activity [77]. This feature is shared with the 
Gap1m family of RasGAP, which also require a C2 domain N-terminal to their RasGAP 
domain to stimulate Rap GTPase activity [78–80]. Thus, SynGAP and the Gap1m family of 
proteins have been dubbed dual-specificity Ras- and RapGAPs. Unique to these dual-
specificity GAPs is the use of a catalytic arginine for both Ras- and RapGAP activities, 
which differs from the canonical use of an asparagine thumb in strict RapGAPs (Figure 3) 
[77,78].    
 Biological evidence for dual Ras- and Rap-specificity is supported by the observation 
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that SynGAP influences both Ras/ERK/MAPK and Rap/P38/MAPK signaling pathways 
[54,64,65]. The intrinsic factors determining RasGAP versus RapGAP, or even simultaneous 
activities are still unfolding. Substrate preference of SynGAP can be altered by 
phosphorylation in the C-terminal tail. Phosphorylation of SynGAP at the C-terminal tail by 
CaMKII enhances RapGAP activity over RasGAP, while CDK5 and Plk2 enhance RasGAP 
above RapGAP function [22,81,82]. However, the importance C-terminal phosphorylation 
for GAP activity in vivo is complicated by the fact that phosphorylation of SynGAP by 
CaMKII removes it from the PSD [66,83,84]. Although the N-terminal domains and C-
terminal tail influence GAP activity, the structural mechanism is unclear. Uncovering the 
structural basis for substrate recognition by SynGAP is prerequisite to fully understanding its 
biochemical and biological function. 
  
Organization of this Dissertation 
The work of this dissertation focused on the structural biology of important 
neurological signaling proteins: nNOS and SynGAP. nNOS and SynGAP are both key 
signaling proteins for neurological development, rearranging neurological circuitry, and 
maintaining synaptic homeostasis. The motivation behind studying these two systems stems 
from common themes between nNOS and SynGAP structural biology: both are large, ~150 
kDa proteins, with modular domain arrangements and multiple flexible regions. These 
characteristics make them challenging targets using mainstay structural techniques such as 
X-ray crystallography or NMR. In this introductory chapter, I briefly described some of the 
biological roles of nNOS and SynGAP. Chapter 2 contains a published study about the 
mechanism of nNOS activation and regulation by phosphorylation. In chapters 3 I present an 
article detailing new insights into SynGAP conformation in solution and novel RapGAP 
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function. Chapter 4 contains new work investigating the role of membrane interactions in 
SynGAP function. Finally, chapter 5 discusses the major conclusions of this dissertation with 
comments on what I think may be fruitful future directions.  
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Figures 
Figure 1: the post-synaptic density is protein-rich signaling hub that mediates neuro-
transmission and intracellular signaling events. This cartoon represents a very simplified 
depiction of the PSD.  
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Figure 2: Within the PSD a multitude of signaling cascades are triggered by calcium flux. A 
simplified overview of key signaling events is depicted here. Ca2+/CaM activates nNOS, 
RasGEFs, CaMKII, adenylate cyclase, and more. Downstream of Ca2+/CaM, Ras and Rap 
are activated leading to LTP or LTD, respectively. SynGAP inhibits both pathways, 
positioning it as a central regulator of LTP/LTD.  
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Figure 3: RasGAPs and RapGAPs follow a “finger-thumb” paradigm. RasGAPs stimulate 
GTPase activity of Ras by contributing an arginine “finger” that neutralizes the net negative 
charge of the - and -phosphates, lowering the energy barrier to GTP hydrolysis. RapGAPs 
on the other hand use an asparagine “thumb” which coordinates a water molecule to attack 
the  phosphate, driving GTP hydrolysis. Dual-specific GAPs follow the same mechanism 
for Ras as a RasGAP. For RapGAP activity, dual-specificity GAPS use an arginine “finger” 
to facilitate GTP hydrolysis. Additionally, an auxiliary domain is required for RapGAP 
function.  
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CHAPTER 2.    CALMODULIN-INDUCED CONFORMATIONAL CONTROL AND 
ALLOSTERY UNDERLYING NEURONAL NITRIC OXIDE SYNTHASE 
ACTIVATION 
 
Abstract 
Nitric oxide synthase (NOS) is the primary generator of nitric oxide signals controlling 
diverse physiological processes such as neurotransmission and vasodilation. NOS activation 
is contingent on Ca2+/calmodulin binding at a linker between its oxygenase and reductase 
domains to induce large conformational changes that orchestrate inter-domain electron 
transfer. However, the structural dynamics underlying activation of full-length NOS remain 
ambiguous. Employing hydrogen-deuterium exchange mass spectrometry, we reveal 
mechanisms underlying neuronal NOS (nNOS) activation by calmodulin and regulation by 
phosphorylation. We demonstrate that calmodulin-binding orders the junction between 
reductase and oxygenase domains, exposes the FMN subdomain, and elicits a more dynamic 
oxygenase active site. Furthermore, we demonstrate phosphorylation partially mimics 
calmodulin-activation to modulate nNOS activity via long-range allostery. Calmodulin-
binding and phosphorylation ultimately promote a more dynamic holoenzyme while 
coordinating inter-domain communication and electron transfer. 
 
Keywords 
Hydrogen-deuterium exchange, mass spectrometry, allosteric communication, nitric oxide 
signaling 
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Abbreviations used: 
nNOS, neuronal nitric oxide synthase; CaM, calmodulin; NO, nitric oxide; HDX-MS, 
hydrogen-deuterium exchange mass spectrometry; CT, C-terminal tail of nNOS; AI, auto-
inhibitory element of nNOS; H4B, tetrahydrobiopterin.  
 
Introduction 
The diatomic gas nitric oxide (NO) serves dual physiological roles as both a signaling 
molecule and inflammation agent. Emitted at minute (nanomolar) concentrations, NO can 
function as a membrane-permeable paracrine signaling agent involved in cardiovascular and 
neurological functions [1-4]. Generated at high (micromolar) levels, NO acts as a potent 
cytotoxic weapon of the immune system. As a free radical, NO production is tightly 
regulated. Indeed, dysfunctional NO regulation is implicated in Alzheimer’s and Parkinson’s 
disease, excitotoxicity, auto-immune disorders, and cardiovascular disease [2-5]. Control 
over NO signaling is primarily exerted by regulating the localization and activation of the 
NO source, nitric oxide synthase (NOS).  
The three mammalian NOS isozymes–  endothelial NOS (eNOS), neuronal NOS 
(nNOS), and inducible NOS (iNOS)– share a general domain organization (Fig. 1a). The 
NOS isoforms are all homodimeric heme-containing oxidoreductases ranging from 260-320 
kDa in molecular mass. The active site heme resides in an N-terminal oxygenase domain 
along with a catalytic tetrahydrobiopterin (H4B) cofactor.  The C-terminal reductase domain 
is divided into an FAD/NADPH-binding subdomain and a mobile FMN subdomain. A 
regulatory calmodulin (CaM)-binding region connects the oxygenase and reductase domains. 
Activity of the constitutively expressed isoforms, eNOS and nNOS, is tightly regulated by 
the binding of Ca2+/CaM. Conversely, conditional protein expression is the primary regulator 
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of the constitutively active iNOS isoform, as Ca2+/CaM binds iNOS irreversibly without 
elevation of cytosolic Ca2+ levels. 
Interdomain conformational changes allow the NOS cofactors to deliver reducing 
equivalents from NADPH to the heme where L-arginine is converted to citrulline and NO. 
During catalysis, the FMN cofactor receives an electron in the reductase domain via a 
conformation known as the input state (Fig. 1b). The FMN subdomain then shuttles the 
reduced FMN to the heme cofactor by undergoing a large-scale conformational change to an 
output state, shifting the FMN subdomain to dock with the oxygenase domain to permit 
electron transfer to the heme [6-11]. CaM binding allows for productive transition from the 
input state to the output state, although the mechanism is not well understood [8, 12, 13]. 
CaM binding is thought to relieve regulatory constraints via unknown mechanisms to liberate 
the FMN subdomain from the FAD/NADPH subdomains [7, 14]. Furthermore, CaM is 
thought to limit the conformational freedom of the FMN subdomain and direct it toward the 
output state while participating in the docking interaction with the oxygenase domain [7, 11, 
15, 16].  
In the absence of CaM, release from the input state is hypothesized to be constrained 
by several regulatory elements in the reductase domain: the autoinhibitory insert (AI) [17-
19], the CD2A hairpin [20], and the C-terminal tail (CT) [21].  Importantly, these regulatory 
elements are unique to nNOS and eNOS, the two regulated NOS isoforms. Deletion of both 
AI and CT eliminates the CaM-dependence of electron flow through the reductase domain 
yet retains the CaM-sensitivity for overall NO production [22]. The CD2A hairpin is also 
thought to play a role in the reductase domain response to Ca2+/CaM binding, although the 
mechanism remains unclear [20]. 
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Recent single-particle EM studies revealed snapshots of accessible higher-order 
domain arrangements involved in the transit of the FMN subdomain between input and 
output states [7, 14]. However, the details of the CaM-induced conformational changes 
remain ambiguous. For example, the mechanism by which CaM releases the FMN 
subdomain from reductase regulatory elements to facilitate inter-domain shuttling is unclear. 
In addition, both the CT and AI regulatory elements contain phosphorylation sites that 
modulate eNOS and nNOS activity, adding another layer of complexity [21, 23, 24].  
The lack of high resolution structures of full-length NOS holoenzymes obscures the 
structural basis for CaM-induced conformational changes and allostery. The three NOS 
isoenzymes have proven difficult to study by NMR and X-ray crystallography. Structures of 
NOS domain truncations have been reported but lack the context of a full-length enzyme [23, 
25-28]. Crystal structures of the reductase domain informed current models of the input state 
[23]. However, observing the output state eludes the highest resolution structural techniques. 
Using hydrogen/deuterium exchange mass spectrometry (HDX-MS) and structural modeling, 
we previously developed a model of the output state for iNOS [11]. Nevertheless, the CaM-
mediated dynamic conformational changes involved in transitioning between input and 
output states are poorly characterized.  Here, we investigate mechanistic models of CaM-
induced activation of NOS using HDX-MS. 
HDX-MS is a useful technique for studying protein folding, protein–protein 
interactions, allostery, and conformational changes [29-34]. HDX-MS measures the rates of 
backbone amide proton exchange to report on local chemical environments. H/D exchange 
rates are influenced by secondary structure, hydrogen bonding, solvent exposure, and protein 
dynamics. As such, exchange rate perturbations are valuable indicators of local protein 
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dynamics and allostery [35-38].  Indeed, HDX-MS was previously used to characterize the 
allostery and conformational changes associated with NO-induced activation of the NOS 
signaling partner, soluble guanylate cyclase [39]. We chose to determine the CaM-induced 
structural perturbations in the nNOS isozyme. nNOS in the brain regulates neurodevelopment 
and synaptic plasticity [3, 40-42]. NO produced by nNOS acts as a retrograde signaling 
molecule with putative collateral paracrine signaling effects. Strict regulation of nNOS 
activity is critical, as dysfunctional neuronal NO signaling is associated with excitotoxicity 
and neurodegenerative disorders [4, 5, 43]. Here, we present HDX-MS data describing the 
shift in conformational dynamics upon CaM-induced nNOS activation and modulation by 
phosphorylation. 
 
Results 
CaM binding perturbs domain interfaces and regulatory elements in the nNOS 
reductase romain.  
CaM binding activates nNOS through mechanisms that are not fully understood. To 
determine the mechanism of nNOS activation by CaM, we employed HDX-MS. H/D 
exchange timecourses were collected for inactive nNOS and Ca2+/CaM-activated nNOS. 
Deuterium incorporation of each uniquely identifiable peptic fragments was assessed using 
LC-MS. Increased rates of deuterium exchange result from disruptions in secondary structure 
and hydrogen bonding, increased dynamics or greater solvent accessibility. Conversely, 
decreased rates of deuterium exchange suggest local stabilization (e.g., formation of 
secondary structure and hydrogen bonding) or lower solvent accessibility. CaM-induced 
changes in nNOS exchange rates were mapped to the primary sequence and color coded (Fig. 
2).  
 
 24 
CaM-induced exchange rate perturbations were evident at several regions distributed 
throughout the holoenzyme. As expected, the region exhibiting the most dramatic CaM-
induced decreases in deuterium exchange rates (> 40%) was the CaM binding site (residues 
731-744, Fig. 3a, Supplementary Fig. S1a). Exchange rate suppression extends to the short 
linker containing R752, a conserved residue believed to coordinate a hydrogen bond network 
between CaM and the FMN subdomain (Fig. 3b) [16, 44, 45]. Importantly, the observed 
peptide coverage enables a dissection of the contributions of the CaM-binding site and the 
adjacent linker. The peptide covering residues 749–758 excludes the direct CaM-binding 
region, allowing us to attribute strong exchange rate suppression to the linker itself 
(Supplementary Fig. S1b).  
The stabilizing effect from the R752 linker also manifests at an FMN subdomain 
loop. This loop, comprising residues 777 to 781, includes residues engaged in a hydrogen-
bonding network with R752 (R536 in human iNOS) in a reported structure of the isolated 
iNOS FMN subdomain bound to CaM (Supplementary Fig. S2) [16]. In contrast to the 
protection of regions adjacent to the CaM-binding site, the rest of the FMN subdomain 
manifests exchange rate increases (Fig. 3c). The deprotection upon CaM binding localizes, in 
part, to two loops surrounding the FMN cofactor (residues 806-815 and 886-892), which also 
form the input state interface with the FAD/NADPH lobe of the reductase domain 
(Supplementary Fig. S3). Surfaces thought to participate in the FMN—oxygenase domain 
interaction (including residues G810, N811, E819, and C823) also undergo significant 
deprotection [11, 44]. These findings are consistent with an overall increase in FMN 
subdomain exposure and/or mobility in CaM-activated nNOS. 
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Multiple regulatory elements reside in the reductase domain, including the CD2A 
hairpin, the AI, and the CT. The CD2A hairpin exhibits pronounced CaM-induced exchange 
rate increases primarily in a -strand within the motif (Fig. 3c). This is likely due to a 
change in the local chemical environment due to the proximity of the bound CaM. Exchange 
rate perturbations were not evident in the CT or AI elements. However, deuterium 
incorporation had largely saturated in these elements before the first measured time point (15 
s), obscuring possible effects at shorter time points. Nevertheless, pronounced increases in 
exchange rate are evident at FMN subdomain surfaces contacting these regulatory elements. 
In addition, a weak enhancement of exchange at NADPH/FMN subdomain residues 1382—
1395 surrounds the AI, evidently due to a CaM-induced conformational change influencing 
the contacts between the AI and FMN subdomain (Fig. 3d). Similarly, we observe 
perturbations upon CaM-binding on the surface of the FMN subdomain proximal to the CT 
(Fig. 3e). 
 
CaM-induced conformational effects in the nNOS oxygenase domain 
HDX results mapped to the nNOS oxygenase domain reveal CaM-induced 
perturbations largely localized to the surfaces surrounding the heme electron transfer access 
point (Fig. 4a).  A small hole around the putative FMN-oxygenase interface (forming the 
output state) allows access to the heme (Fig. 4b) [11, 16]. Deuterium exchange increases 
manifest at the “lip” of this heme access point (residues 416-424). Flanking this region, the 
outside edge of the oxygenase domain shows modest deuterium exchange rate increases. In 
addition, a short peptide encompassing W587 is also perturbed by CaM-binding (Fig. 4b, 
Supplementary Fig. S4). Tryptophan at this position is invariant across NOS isoforms that 
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employ a flavodoxin reductase and plays a critical role in facilitating electron transfer from 
the FMN cofactor to the heme [11, 16, 46]. Together with the reductase domain results 
described above, perturbations at the heme access point and FMN subdomain appear to be 
the primary hallmarks of activated nNOS. 
 
nNOS phosphomimetic variants modulate NOS activity 
Our results reveal that CaM binding induces striking exchange rate perturbations in 
regions surrounding known sites of phosphorylation in the AI and CT (Fig. 3d-e). 
Phosphorylation of AI residue S847 or CT residue S1412 modulates the activity of nNOS. In 
cells, S847 phosphorylation decreases the activity of nNOS [24, 47]. S1412 phosphorylation, 
on the other hand, stimulates nNOS signaling pathways [48-50]. Introducing substitutions of 
serine to aspartate often mimics the negative charge of a phosphoserine, serving as a 
phosphomimetic. Indeed, both S847D and S1412D mimic the modulation of nNOS behavior 
in cells [51]. Purified S847D recapitulates decreased nNOS activity observed in cells [52]. 
The effects of S1412D substitution largely manifest as increases in electron transfer flux 
through the reductase domain [53]. We aimed to determine the influence of phosphomimetics 
on nNOS structural dynamics and CaM-induced activation. To this end, we generated nNOS 
variants S847D and S1412D. Our characterization of the steady state kinetics of NO 
production and electron transfer activity agree well with previous reports (Supplementary 
Fig. S5) [52, 53]. 
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Phosphomimetic variants of nNOS demonstrate synergistic perturbations with CaM 
binding 
Comparisons of the H/D exchange rates for CaM-activated S1412D and S847D 
relative to WT nNOS reveal additive conformational perturbations beyond the CaM-binding 
effects. Both phosphomimetic variants increase protection at the CaM-binding helix relative 
to WT nNOS, with no change in the R752 linker (Fig. 5). At the FMN subdomain both 
S847D and S1412D induce deuterium exchange increases, with the strongest perturbations 
near the FMN cofactor and putative output state interface. The effects of S847D and S1412D 
diverge in the oxygenase domains. CaM-stimulated S847D exhibits modest protection 
around the heme electron transfer access point (residues 416-424) and a moderate protective 
effect on the electron-conducting residue W587 relative to CaM-bound WT. Conversely, 
widespread deuterium exchange rate increases are observed in the oxygenase domain of 
S1412D nNOS. S1412D perturbs a broader surface than CaM-bound WT or S847D, 
suggesting the S1412D variant has a stronger effect on output state conformational dynamics. 
Taken together, these data suggest both nNOS phosphomimetic variants effect the input state 
population similarly but have differing ramifications on output state population. 
 
Dissecting contributions of phosphomimetics and CaM in nNOS activation 
 S847 and S1412 phosphorylation are thought to tune nNOS activity by disfavoring 
the input state conformation [51]. However, the conformational dynamics induced by S847 
and S1412 phosphorylation was unclear.  To test the allosteric consequences attributable to 
phosphorylation, we compared H/D exchange rates for the nNOS WT and phosphomimetic 
variants in the absence of CaM. Strikingly, both nNOS phosphomimetics manifested H/D 
exchange perturbations in both reductase and oxygenase domains (Supplementary Fig. S6). 
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For both phosphomimetics the FMN subdomain was deprotected at surfaces adjacent to the 
sites of phosphorylation in the AI and CT. These perturbed FMN subdomain surfaces are 
also implicated in both the input and output state conformations. Surprisingly, both 
phosphomimetic variants also showed subtle perturbations in the oxygenase domain. The 
heme access point exhibited increased perturbation due to S1412D and decreased 
perturbation in S847D. As these results parallel perturbations observed in the presence of 
CaM (Fig. 5), the dynamic changes observed appear to derive from the phosphomimetic 
variants.  
 Although the nNOS S847D and S1412D variants share some of the markers of 
activation independent of CaM (i.e., increased exchange at the FMN subdomain), neither 
phosphomimetic produces NO without CaM binding. While phosphorylation appears to 
potentiate the conformational dynamics of nNOS, CaM-binding induces a unique 
conformational effect required for productive NOS activity. To dissect the CaM-induced 
contributions to the activation of phosphomimetic nNOS variants, we compared CaM-free 
and CaM-bound S847D or S1412D nNOS (Supplementary Fig. S7). For both variants, CaM 
ordered the CaM-binding helix and reinstated the apparent rigidification of the R752-
containing linker. Additionally, the CD2A hairpin showed increased deuterium exchange in 
both phosphomimetics. Furthermore, both variants exhibited enhanced deuterium exchange 
in the FMN subdomain at surfaces that participate in the output state. This was 
complemented by a further increase in deuterium exchange at the heme access point for both 
variants. Taken together, the intrinsic conformational changes induced by nNOS S847D and 
S1412D variants share some features with CaM-activated WT nNOS. However, the 
increased dynamics associated with the phosphomimetics are insufficient to activate NO 
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production. Our data suggest the following: i) FMN subdomain release is sensitive to 
multiple factors, ii) NO production depends on CaM to order the R752 linker and coordinate 
the FMN subdomain movement, and iii) conformational dynamics intrinsic to 
phosphomimetic variants can act synergistically (S1412D) or in opposition to (S847D) CaM-
activation of nNOS. 
 
Discussion 
Illuminating the mechanisms by which CaM orchestrates the inter-domain shuttling 
of NOS is a prerequisite to understanding physiological control of NO signaling. HDX-MS 
of full-length nNOS and phosphomimetic variants, reported herein, allowed direct 
identification of key conformational changes in nNOS activation. Our data revealed that 
CaM-binding induces changes in dynamics and conformation throughout the nNOS domains. 
Prominent structural perturbations localize to the heme electron transfer access point of the 
oxygenase domain (Fig. 4), the CaM binding linker, and key regulatory interfaces of the 
reductase domain (Fig. 3). Moreover, CaM-induced allosteric effects surround 
phosphorylation sites known to tune NOS activity. The phosphomimetic nNOS variants 
reveal how phosphorylation may induce significant conformational perturbations in nNOS 
(Fig. 6).  Furthermore, comparison of CaM-bound and CaM-free phosphomimetics highlights 
the importance of CaM-specific conformational changes to productively communicate 
between reductase and oxygenase domains. 
The most pronounced structural change for WT nNOS and the phosphomimetic 
variants due to CaM-binding appears in the CaM-binding linker. The strong protection 
elicited by CaM-binding is consistent with the high affinity of the interaction (Kd ~ 2-6 nM) 
[54, 55]. However, protein–protein interactions alone do not typically evoke such a strong 
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protection; changes in backbone hydrogen-bonding, especially secondary structure, usually 
dominate exchange rates. Previous studies suggest that the NOS CaM-binding linker is 
unstructured and highly flexible in the absence of CaM [15, 16, 56, 57]. The large magnitude 
exchange suppression is consistent with CaM-binding inducing formation of the helix 
observed in reported co-structures of the CaM-bound iNOS linker [16]. The CaM-bound 
helix adjoins the FMN subdomain via a short hinge region containing the strictly conserved 
R752. Strong protection specific to the hinge is consistent with stabilization and reduced 
dynamics (Fig. 3b). CaM-binding also alters the structure and/or stability of regulatory 
interfaces.  Most prominently, the CD2A hairpin undergoes striking deprotection. CD2A was 
proposed to influence the Ca2+-dependency of nNOS activation via an ambiguous mechanism 
[20]. The CaM-induced effects on the CD2A hairpin suggest dissociation or deformation of 
the regulatory element. 
A consistent finding of the HDX studies is that control of nNOS activation – via 
CaM-binding (Fig. 3) or phosphomimetics (Fig. 5) – impacts FMN subdomain structural 
dynamics. Multiple lines of evidence indicate that CaM binding promotes electronic 
deshielding of the FMN subdomain during NOS activation [45, 58]. Additionally, CaM 
binding is thought to promote release of the FMN subdomain from the rest of the reductase 
domain [7, 12, 14]. Here, we mapped specific FMN subdomain surfaces deprotected by CaM 
binding, thereby supporting the hypothesis that CaM liberates the FMN subdomain from the 
FAD/NADPH binding lobe, shifting the conformational ensemble away from the input state. 
NOS activation requires the enzyme to shuttle electrons productively between input 
and output state. Our data indicate a population shift away from the input state upon CaM-
induced NOS activation, but evidence for a stabilized output state population is less evident. 
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We observed CaM-induced exchange rate increases around the heme electron transfer access 
surface (Fig. 4). Increased exchange rates may be attributable to local conformational 
changes (e.g., rearrangements of backbone H-bonding) along the heme access surface during 
output state docking. Alternatively, this deprotection could reflect a global increase in nNOS 
structural dynamics upon CaM-induced catalytic cycling. Nevertheless, a stable oxygenase 
domain interface encompassing FMN subdomain and CaM docking sites was not apparent by 
HDX. Strikingly, this result contrasts with previous HDX-MS mappings of the iNOS output 
state inter-domain interactions [11]. However, the iNOS HDX-MS study employed domain 
truncations designed to promote formation of the output state. The more limited effects 
observed here for activated nNOS may be due to the transience of the output state 
interactions relative to the input state  [12, 13, 45, 59]. Transient output state interactions 
relative to the input may be important for protecting reducing equivalents from NADPH from 
being transferred to alternative electron acceptors like dioxygen. Indeed, other enzymes with 
multi-domain diflavin reductase domain architectures, such as NADPH-cytochrome P450 
oxidoreductase, exhibit similarly glancing interactions with redox partners [60, 61]. 
Previous fluorescence decay experiments suggest that nNOS exchanges between the 
input state and a neutral open state when inactive with only a small population of the output 
state sampled [13, 59]. Upon activation by CaM binding, the population shifts from the input 
state to the output state, but the open state still dominates. Furthermore, the lifetime of the 
output state is not enhanced upon activation, suggesting that a productive output state is 
transient [13]. In addition, productive orientation of the output state is thought to be governed 
by side-chain charges, an interaction that may not substantively influence the backbone 
amide protons measured by HDX [11, 44, 46]. Previous studies identified extensive 
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oxygenase domain docking surfaces for productive interdomain alignment, association, and 
electron transfer [7, 11, 46]. Nevertheless, the limited, localized output state “footprint” 
observed herein highlights the transience of the output state interface. A brief output state 
interaction would allow for rapid cycling of the FMN subdomain back to the input state for 
additional reducing equivalents to complete the synthesis of NO. Indeed, three distinct 
electron transfer events from FMN to heme are required for each NO molecule produced 
[62]. 
Transition between the input state and output state conformational regimes requires 
release of the FMN subdomain from the rest of the reductase domain. CaM binding and 
phosphomimetic mutations induced deuterium exchange increases, suggesting release of the 
FMN subdomain. Increased rates of electron transfer for phosphomimetic variants (with or 
without CaM) and CaM-bound nNOS WT also suggest a more dynamic FMN subdomain [9, 
63, 64]. However, CaM is required for NO synthesis, suggesting the release of the FMN 
subdomain does not inherently coincide with a population shift toward the productive output 
state, but toward an open intermediate state. These findings agree with recent investigation 
by Dai, et al. exploring the critical roles of FMN subdomain dynamics and CaM-directed 
communication between nNOS domains [65]. Chemical crosslinking of the FMN subdomain 
to the FAD/NADPH subdomain dramatically attenuates the ability of CaM to stimulate 
electron transfer. Furthermore, lengthening the inter-domain linkers also diminishes CaM-
induced activation. 
Curiously, phosphomimetic variants of nNOS induce H/D exchange perturbations at 
the heme access point in the absence of CaM (Fig. 5, 6, Supplementary Fig. S6). This 
suggests that long-range allostery from the reductase domain primes the oxygenase domain 
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for activity (or diminished activity in the case of S847D). In the context of FMN subdomain 
release and the transiency of the output state, our data suggest nNOS activation also requires 
a priming of the oxygenase conformation to prepare for interdomain electron transfer. For the 
S1412D variant, this allosteric priming manifests as an increase in exchange in the oxygenase 
domain, while the S847D variant exhibits an opposing decreased exchange. These changes in 
apparent oxygenase dynamics correlate with the increase of nNOS activity upon S1412 
phosphorylation, and decrease for S847 phosphorylation [24, 51, 52, 66, 67]. Nevertheless, 
CaM binding is necessary and sufficient for eliciting the key conformational changes 
associated with productive inter-domain electron trafficking (e.g., FMN subdomain release, 
productive oxygenase domain contact), relegating phosphorylation to role in tuning the 
degree of activation. 
While the lifetime and occupancy of NOS conformational states has been explored 
using time-resolved fluorescence spectroscopy, questions remain regarding the influence of 
phosphorylation [13, 59]. We surmise that the decreased exchange rates manifest in the 
S847D variant (with and without CaM) indicate a shift toward a more stable output state. 
Indeed, removal of the AI, which contains S847, appears to stabilize the output state of CaM-
bound nNOS [17, 22]. In the input state, the AI is positioned between the FMN- and 
NADPH-binding regions. Phosphorylation and CaM-binding may free the AI to stabilize the 
output state, hence the observed decrease in exchange rates as a function of S847D and CaM-
binding. Conversely, S1412 phosphorylation may have the opposite effect of S847 
phosphorylation. Rather than stabilizing the output state, S1412D may enhance the 
conformational flux of nNOS catalytic cycle. Accordingly, deletion of the CT, which 
includes S1412, promotes faster electron transport in the reductase domain, and small 
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quantities of NO can be produced independent of CaM [21, 22]. This may indicate a more 
dynamic FMN subdomain without a stabilized output state. Future structural and 
spectroscopic interrogations of the role of the CT, AI, and phosphorylation may resolve these 
details. 
Overall, our results reinforce the utility of HDX-MS as a tool for probing 
conformational changes and dynamics in large, multi-domain proteins. The NOS family 
proteins are prime examples of the challenges associated with deciphering the regulatory 
mechanisms of both signaling proteins and enzymes with elaborate electron transport 
systems. Hallmarks of both classes of proteins include multi-domain architectures with 
highly flexible linkers allowing for dynamic, regulated inter-domain communication. The 
large size and conformational heterogeneity of these enzymes present daunting obstacles to 
most structural biology approaches. HDX-MS is well-suited to probing dynamics in large, 
flexible proteins. Integrating HDX-MS data with the wealth of reported structures detailing 
individual enzyme domains provides a route to building higher-order models of complex 
enzyme activation mechanisms. Likewise, the integrative structural biology approach can 
illuminate cryptic allosteric pathways communicating regulatory protein interactions and 
post-translational modifications.  
 
Materials and Methods 
Protein expression and purification 
All nNOS constructs were co-expressed with chaperone GroEL in BL21(DE3) cells in 
Terrific broth supplemented with 80 mM KH2PO2 pH 7.8. Cells were grown at 37 °C while 
shaking to OD600 nm ~ 0.6. Cells were induced with 0.5 mM isopropyl -D-1-
thiogalactopyranoside (IPTG) supplemented with 0.45 mM ∂-aminolevulinic acid and 5 µM 
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riboflavin to promote heme and FMN biosynthesis. Induced cells were incubated 35 hr at 20 
°C while shaking. Cells were harvested by centrifugation and frozen at -80 °C. Frozen cell 
pellets were resuspended in 50 mM Tris pH 8.0, 5 mM DTT, 1 mM EDTA, 0.5 mM L-
arginine, 10 µM H4B, 10% (v/v) glycerol then lysed using an Emulsiflex-C3 homogenizer. 
Insoluble cell debris was separated by centrifugation at 20,000 ×g for 60 min. Clarified 
lysates were supplemented with 2 mM CaCl2 and applied to CaM-Sepharose 4B resin (GE 
Healthcare) preequilibrated with binding buffer (50 mM Tris pH 8.0, 5 mM DTT, 2 mM 
CaCl2, 10 µM H4B, 10% (v/v) glycerol). The column was washed with binding buffer 
supplemented with 300 mM NaCl until the Abs280nm baseline stabilized. Protein was eluted 
with 50 mM Tris pH 8.0, 250 mM NaCl, 5 mM DTT, 5 mM EGTA, 10 µM H4B, 10% (v/v) 
glycerol, concentrated in 10 kDa molecular weight cut-off (MWCO) spin concentrators, 
aliquoted, and snap frozen in liquid N2. Protein concentration was determined using the 
Bradford assay with a BSA standard curve. 
 CaM was expressed in BL21(DE3) cells. Cells were grown at 37 °C with shaking to 
OD600 nm ~ 0.6 and induced with 0.5 mM IPTG. Protein expression continued overnight at 28 
°C with shaking. Cell harvesting and lysis was performed as with nNOS but with the 
substitution of a CaM lysis buffer (50 mM Tris pH 7.8, 100 mM NaCl, 2 mM CaCl2, 1 mM 
DTT, 1 mM PMSF). Clarified cell lysate was applied to Phenyl Sepharose 6 FF resin (GE 
Healthcare) and further washed with CaM lysis buffer. CaM retained by the resin was further 
washed in a high salt buffer (50 mM Tris pH 7.8, 500 mM NaCl, 2 CaCl2, 1 mM DTT). CaM 
was eluted in buffer supplemented with EGTA (50 mM Tris pH 7.8, 100 mM NaCl, 2 mM 
EGTA, 1 mM DTT). Elution fractions containing CaM, as assessed by SDS-PAGE, were 
pooled, concentrated in a 10 kDa MWCO spin concentrator, and buffer exchanged into CaM 
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storage buffer (50 mM HEPES pH 7.5, 100 mM NaCl, 1 mM DTT) using an Econo-Pac 
10DG column (Bio-Rad). Buffer exchanged CaM was aliquoted, snap frozen in liquid N2, 
and stored at -80 °C.  
 
Hydrogen-deuterium exchange mass spectrometry 
H/D exchange time courses were performed as previously described [39]. nNOS samples 
were buffer exchanged into 50 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM DTT, 10 µM H4B 
and concentrated to 10 µM. H/D reactions done with CaM included 500 µM CaM before 
diluting into buffered D2O. Deuterium exchange was initiated by dilution of protein stocks 
into buffered D2O (50 mM HEPES, pD 7.5, 100 mM NaCl, 5 mM DTT). Exchange was 
quenched at 15, 45, 900, or 7200 s by addition of 5% (v/v) trifluoroacetic acid to pH 2.5 and 
flash freezing in liquid N2. For digestion into uniquely identifiable peptides, each time point 
sample was rapidly thawed and digested using agarose-immobilized pepsin (Pierce) for 3 min 
at 4 °C in 0.025% TFA pH 2.5. Pepsin resin was removed by centrifugation, and samples 
were immediately refrozen in liquid N2. Samples were stored at -80 °C until analysis. Pepsin 
digestion products were identified by LC-MS/MS as previously described [68]. Exchange 
samples were rapidly thawed immediately prior to injection into an Agilent 1260 HPLC 
equipped with a C8 reversed phase analytical column (Pinnacle DB 5 µm particle, 30 mm × 1 
mm, Restek) connected in-line with a Q-Exactive Orbitrap (Thermo) mass spectrometer with 
a HESI-II electrospray ionization source (Thermo). Analytical column, inlet tubing, and 
injector were maintained at 0 °C - 4 °C and preequilibrated with 0.1% formic acid/10% ACN 
chilled to 4 °C. Peptides were eluted using a linear gradient from 10 – 25% over 2.5 min  
 
 37 
followed by 5.5 min ramp to 55% ACN. Mass spectra were collected in positive-mode (m/z 
range of 300-1,800) at a mass resolution setting of 70,000.  
 
HDX-MS data analysis 
HDX-MS data were processed and analyzed using HDX Workbench [69]. PyMol was used 
for imaging structures and mapping HDX-MS results. Exchange rate differences ( %D) are 
reported for a time point representative of the actively exchanging regime of the timecourse. 
Statistical significance was determined using a two-tailed unpaired T-test [68]. 
 
Supporting Information 
Supporting methods 
nNOS activity assays 
NO production assays were performed as previously described. 1 Briefly, NO 
production was measured by observing the change in oxyhemoglobin (HbO2) absorbance at 
401 nm using an extinction coefficient of 60 mM-1 cm-1. All activity assay reactions 
contained 100 mM HEPES, pH 7.5, 100mM NaCl, 10 mM L-arginine, 10 mM CaCl2, 6.5 
µM H4B, 20 µM HbO2, 1 µM CaM and 30 nM nNOS variant. NOS activity was initiated by 
adding NADPH to 100 µM. NADPH oxidation was monitored simultaneously at 340 nm 
using an extinction coefficient of 6.22 mM-1 cm-1. Reductase activity was determined by 
measuring DCIP and cytochrome c reduction. 2 Cytochrome c reduction was measured by 
monitoring 550 nM and an extinction coefficient of 21 mM-1 cm-1. DCIP reduction was 
measured by monitoring 600 nM using an extinction coefficient of 20.6 mM-1 cm-1. All 
assays were performed in triplicate. 
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HDX-MS time course plots 
HDX-MS time courses were exported from HDX Workbench3 and plotted using 
GraphPad Prism (GraphPad Software). All data points are the average of three replicates of 
individual H/D exchange reactions (see main text for methods). 
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Supporting figures 
Figure S1. Representative time courses of HDX-MS results for peptides discussed in the 
main text. Relates to figure 3A/B of the main text. A) Peptides covering the CaM-binding 
region of nNOS display significant CaM-dependent reduction in deuterium exchange. B) The 
R752-containing peptide neighbors the CaM-binding site, but manifests less dramatic 
perturbations. All data represented are the average of three replicates. Error bars represent 
standard deviation, and are smaller than the marker in some cases. 
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 Figure S2. Relates to figure 3C in the text. A representative time course from a peptide in 
the FMN subdomain, which participates in the R752-mediated hydrogen bonding network. 
All data represented are the average of three replicates. Error bars represent standard 
deviation, and are smaller than the marker in some cases. 
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Figure S3. Relates to figure 3C. Peptides near the FMN cofactor binding site manifest 
increased H/D exchange in a CaM-dependent manner. All data represented are the average of 
three replicates. Error bars represent standard deviation, and are smaller than the marker in 
some cases. 
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Figure S4. Relates to figure 4 in the main text. Representative time courses showing H/D 
perturbations in the “lip” of the heme access point (left) or the gating W587 residue (right). 
All data represented are the average of three replicates. Error bars represent standard 
deviation, and are smaller than the marker in some cases. 
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Figure S5. A) Initial rates of NO production and NADPH oxidation were determined in the 
presence of CaM for WT and mutant nNOS variants. White squares, WT nNOS rates; black 
triangle, nNOS S847D rates; grey circles, nNOS S1412D rates. B) Cytochrome C reduction 
(charcoal boxes) and DCIP reduction (light grey boxes) were determined for all nNOS 
variants in the presence and absence of CaM. All assays were performed as stated in 
materials and methods. Cytochrome C reduction rates were determined by measuring the 
increase in absorbance at 550 nm and an extinction coefficient of 21 mM-1 cm-1. DCIP rates 
were determined by monitoring absorbance decay at 600 nm and an extinction coefficient of 
20.6 mM-1 cm-1. Errors bars represent standard deviation for three replicates. (*p < 0.05 
relative to WT without CaM; **p<0.05 relative to WT+CaM) 
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Figure S6. Phosphomimetic-induced perturbation in CaM-free nNOS. H/D exchange rates of 
S847D and S1412D variants were compared to WT in the absence of CaM. Exchange rate 
differences are color coded according to the scale bar. Left column shows exchange rate 
perturbations mapped on to the reductase domain (PDB: 1TLL) with FMN subdomain 
outlined in light green. Right column shows perturbations mapped on to the oxygenase dimer 
(PDB: 1OM4). 
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Figure S7. CaM-induced exchange rate perturbations for the S847D or S1412D variants 
were mapped on to ribbon diagram structures. Degree of exchange rate perturbations are 
color coded according to the scale bar. Left column depicts exchange rate perturbations 
mapped on to reductase domain (PDB: 1TLL). Middle column depicts exchange rate 
perturbations mapped on to the oxygenase domain dimer (PDB: 1OM4). Right column shows 
exchange rate perturbations mapped on to the CaM-binding site (PDB: 3HR4). 
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Figures 
 
 
Fig. 1. NOS domain organization and conformational states 
A) NOS isoforms are composed of an N-terminal oxygenase domain, a C-terminal reductase 
domain, and an intervening CaM-binding linker. The oxygenase mediates homodimerization 
and encloses the active site heme. The reductase domain is further divided into an 
FAD/NADPH subdomain and a mobile FMN subdomain. The nNOS isoform also includes 
an N-terminal PDZ domain (not pictured) for synaptic localization. B) CaM-binding 
promotes the productive shuttling of the FMN subdomain between input and output states to 
deliver electrons from the reductase domain to the oxygenase domain. In the input state the 
FMN subdomain associates with the NADPH/FAD subdomain, allowing transfer of reducing 
equivalents from NADPH to FAD to FMN. In the output state FMN transiently associates 
with the oxygenase domain of the other homodimer subunit, to allow electron transfer from 
FMN to heme. 
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Fig. 2. CaM-induced exchange rate perturbations in nNOS. Peptide coverage is represented 
by bars mapped to primary sequence. Exchange rate perturbations are reported as the average 
difference in %D incorporation at time points approximating the midpoint of exchange. 
Peptides exhibiting significant (p<0.05) exchange rate perturbations are color coded 
according to the scale bar (top). Significance was assessed with a two-tailed unpaired 
Student’s t test. Peptides exhibiting undetectable or nonsignificant differences in exchange 
are colored in grey. Sites of phosphorylation are noted in red. Residues W587 and R752 are 
highlighted in yellow and purple, respectively. 
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Fig. 3. CaM-Induced conformational changes mapped onto the nNOS reductase domain. 
Calmodulin induces conformational changes in nNOS reductase domain. All images are 
color coded to according to the scale bar to indicate change in %D. A) HDX results mapped 
on to the human iNOS CaM-FMN subdomain structure (PDB 3HR4). Key features are 
emphasized by highlighting. Yellow spheres represent CaM-bound Ca2+. B) R752 
coordinates a hydrogen bonding network between CaM and the FMN subdomain. NOS 
residues are numbered according to rat nNOS, not iNOS. For clarity, nitrogen atoms in panel 
B are colored yellow rather than the standard blue C) HDX results mapped to the structure of 
the nNOS reductase domain (PDB 1TLL). Perturbations localize primarily to the FMN 
subdomain, outlined in light green. D) A hydrophobic pocket around the AI undergoes CaM-
induced perturbations. E) The obverse surface of the nNOS reductase domain, where the CT 
is localized, is perturbed in a CaM-induced manner. 
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Fig. 4. CaM-induced conformational changes mapped to the nNOS oxygenase domain 
A) CaM-induced perturbations in WT nNOS mapped on to the oxygenase domain structure 
(PBD: 1OM4). Arrow points to heme electron transfer access point. Perturbations were color 
coded according to the scale bar below. The oxygenase domain dimer interface is marked 
with a dotted line. B) Close up of the heme access point. Residues 416-424 form the lower 
“lip” of the heme access point. W587 (side chain shown, nitrogen colored blue) is a key 
residue that coordinates electron transfer from FMN to the heme. Heme is represented as red 
stick models. 
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Fig. 5. Phosphomimetic-induced conformational perturbations mapped to nNOS 
domain models. H/D exchange rates of CaM-activated nNOS S847D or S1412D were 
compared to CaM-activated nNOS WT were measured and mapped to NOS domain models. 
Exchange rate differences ( %D) were color coded according to the scale bar. Left column: 
Increased protection of the CaM-binding helix due to phosphomimetic mutations are mapped 
to the corresponding residues of the human iNOS CaM-FMN subdomain co-structure (PDB: 
3HR4). Middle: Reductase domain perturbations are localized to FMN subdomain (outlined 
in light green) for both phosphomimetic variants. Exchange rate differences were mapped to 
the nNOS reductase domain (PDB: 1TLL) with the iNOS CaM-binding region (PDB: 3HR4) 
modelled in using PyMol. Cofactors are shown as yellow stick models. Right column: 
Exchange rate perturbations mapped on to nNOS oxygenase domain (PDB: 1OM4) reveal 
differing oxygenase domain dynamics for nNOS S847D and S1412D. Heme is represented 
by red stick models. 
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Fig. 6. Localizing activation-associated conformational perturbations to nNOS domains. 
Exchange rate perturbations associated with CaM-binding or phosphomimetics were 
condensed and mapped to a cartoon representation of the nNOS domain organization. 
Differences in %D incorporation are color-coded according to the scale bar below.  
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CHAPTER 3.    ALLOSTERIC BASIS OF RAP1B SUBSTRATE RECOGNITION BY 
SYNGAP 
Introduction 
 SynGAP is a neuron-specific dual-specificity GTPase activating protein, which is 
thought to be a central regulator of neuroplasticity and synaptogenesis [1–3]. SynGAP is 
localized to the post-synaptic density (PSD), where it is found in remarkably high abundance 
[4,5]. Although the details of SynGAP function within the brain is still unfolding, the 
necessity of SynGAP for brain development was established in SynGAP-/- mice, which die 
shortly after birth [6,7]. Mutations in SynGAP have been implicated in 3% of instances of 
autism spectrum disorder, schizophrenia, severe intellectual disability, and epilepsy [8–14]. 
The essential role of SynGAP in neurodevelopment and plasticity has defined it as a principal 
molecule of interest in neurobiology [15].  
  SynGAP (UniprotKB – Q96PV0) is a large protein of roughly 150 kDa with an N-
terminal half containing a putative pleckstrin homology (PH) domain, a C2 domain, and a 
RasGAP homology domain [16,17]. The C-terminal half contains multiple putative regions 
for protein-protein interactions and phosphorylation [18–21]. Although it contains a RasGAP 
homology domain, SynGAP stimulates Rap GTPase activating with higher efficiency than 
Ras [18,22]. Early studies of SynGAP demonstrated that the RasGAP domain alone has 
RasGAP, but not RapGAP, activity. At minimum, the C2 domain must also be present for 
RapGAP functionality [22]. The GAP1m family of GAPs also possess RasGAP homology 
domains and require at least one of their two tandem C2 domains to stimulate Rap GTPase 
activity [23]. However, the mechanism behind how these auxiliary domains enable RapGAP 
function remains unclear. 
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 Our goal in this study is to determine how the C2 domain of SynGAP enables 
RapGAP activity. The groundwork for this study was established by Pena et al., who 
demonstrated the requirement of the C2 domain for RapGAP activity [22]. Based on a crystal 
structure of the C2GAP fragment, Pena and colleagues proposed the C2 domain contacts the 
switch II region of Rap1b, thereby enabling RapGAP activity. The Gap1m family contains 
two C2 domains N-terminal to the RasGAP domain, which correspond to the PH and C2 
domain in SynGAP. For Gap1IP4BP, a member of the Gap1m family, the distal C2 domain 
(corresponding to the SynGAP PH domain) is required for RapGAP activity [24]. This 
suggests that dual-specificity Ras- and RapGAPs may employ long-range communication, 
either allosteric or by bring distant domains in contact with the substrate, for RapGAP 
activity. We investigated intradomain communication for SynGAP using hydrogen-
deuterium exchange mass spectrometry (HDX-MS) and small-angle X-ray scattering 
(SAXS). Our findings extend our understanding of how the C2 domain contributes to 
RapGAP function in SynGAP by providing a solution-state perspective on the structural 
biology governing SynGAP function.  
 
Methods 
Expression, purification of SynGAP/GTPase constructs 
 SynGAP (Harvard PlasmID: HsCD00080382) variants PHC2GAP (residues 146-
725), C2GAP (residues 246-725), GAP (residues 414-725), and Rap1b (Harvard PlasmID: 
HsCD00000705) were cloned into a pBAD vector by Gibson assembly to produce 
pBAD:H6-SUMO-SynGAP variant and pBAD:H6-SUMO-Rap1b. Protein expression was 
achieved by transforming SynGAP constructs into Tuner(DE3) pLysS cells. Small starter 
cultures were grown overnight to saturation in Luria broth (LB) supplemented with 100 
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µg/mL ampicillin (Amp) and 34 µg/mL chloramphenicol (Cam). Cultures were diluted 1:100 
into 1L LB with Amp/Cam and grown at 37 °C with shaking. Once OD600nm reached 0.5, the 
temperature was lowered to 18 °C and protein expression was then induced by adding 10 mL 
of 10% L-arabinose in 50% glycerol. Protein expression continued for 24 hours after 
induction. Cells were harvested by centrifugation at 4,000 rpm and the resulting pellet was 
stored at -80 °C until ready for purification. 
 To purify protein, frozen cell pellets were resuspended in lysis buffer, 50 mM Tris 
(pH 8.0), 150 mM KCl, 15 mM imidazole, 5 mM -ME, 10% glycerol, using a ratio of 1.5 
mL buffer per gram of cell pellet. Resuspended cells were supplemented with 1 mM PMSF, 
then lysed using an Emulsiflex C3 homogenizer. Cell lysate was clarified by centrifugation at 
20,000 ×g for 1 hour at 4 °C. The supernatant of the clarified lysate was then applied to a Ni-
NTA agarose (Thermo) column equilibrated in lysis buffer. Once immobilized, protein was 
washed with 50 mM Tris (pH 8.0) 200 mM KCl, 25 mM imidazole, 5 mM -ME, 10% 
glycerol until the UV baseline stabilized. Protein was then eluted in 50 mM Tris, pH 8.0, 150 
mM KCl, 250 mM imidazole, 5 mM -ME, collecting 1 mL fractions. Fractions with high 
absorbance at 280 nm were pooled for dialysis and H6-SUMO tag cleaving. H6-Ulp1 was 
added to the pooled fractions which were dialyzed against 50 mM Tris, (pH 8.0) 150 mM 
KCl, 2 mM DTT for three-five hours. After SUMO tag cleavage, the dialyzed sample was 
reapplied to a clean Ni-NTA column and the flow through (containing the isolated 
PH/C2/GAP protein) was collected. Protein was concentrated using Amicon Ultra-15 
Centrifugal Filter units (EMD Millipore) with a 10 kDa filter. Protein purity was assessed by 
SDS-PAGE. Purified protein was split into 5-10 µL aliquots, snap frozen in liquid nitrogen, 
and stored at -80 °C. 
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GTPase assays 
Rap1b pre-loaded with GTP or the non-hydrolyzable GTP analogue Guanosine-5`-
[(ß,)-methyleno]triphosphate (GppCp, Jean Bioscience) by incubating 100 µM small 
GTPase with 1 mM GTP in 50 mM HEPES, pH 7.4, 150 mM KCl, 12.5 mM EDTA for 45 
minutes at room temperature. GTP loading was quenched by adding MgCl2 to 25 mM, then 
buffer exchanging through al SuperDex 75 (GE Healthcare) column into 50 mM HEPES, pH 
7.4, 100 mM KCl, 5 mM MgCl2. Prior to measuring GTPase activity, Rap1b was loaded with 
GTP-y-32P (0.5 µCi 32P/10 µL reaction) by adding EDTA to 12.5 mM incubating on ice for 
45 minutes. Exchange was quenched by adding MgCl2 to 25 mM and 32P-loaded GTPase was 
used for assays. 
 Michaelis-Menten kinetics of SynGAP variants were determined using a TLC-based 
assay. Progress curves for 1 nM SynGAP variant across a range of 1-400 µM Rap1b were 
determined by first diluting SynGAP into 50 mM HEPES (pH 7.4), 150 mM KCl, 2 mM 
DTT, 10 mM MgCl2. 5 µL of SynGAP variant was then mixed with 5 µL of Rap1b loaded 
with GTP-y-32P and incubated at room temperature. Every 2 minutes, for a total of 10 
minutes, 1 µL was removed from the reaction, quenched in 50% formic acid, and spotted on 
a PEI-Cellulose plate (EMD Millipore). Reactions were initially monitored for 30 minutes to 
ensure linearity during time course; the fastest reaction began to plateau around 20 minutes. 
After all time points were collected free phosphate and GTP were separated by TLC using a 
mobile phase of 900 mM guanidinium HCl, 100 mM EDTA. Relative amounts of GTP and 
free phosphate were quantified using a Typhoon FLA 9500 (GE Healthcare) 
phosphorimager. Initial rates were determined from progress curves by linear regression 
using GraphPad Prism.  
 62 
 For all other GTPase assays relative activity was determined using the charcoal 
method. 0.5 µM SynGAP variants (truncation or mutant variant) was incubated with 100 µM 
GTP-y-32P-loaded Rap1b to a volume. GTP hydrolysis was stopped at 5 and 10 minutes by 
removing 5 µL from the reaction, quenched in 500 µL of ice-cold charcoal solution (7% w/v 
activated charcoal in 20 mM NaH2PO4, 1 M HCl, 20% ethanol) and vortexed to adsorb 
protein and GTP to charcoal. Charcoal was pelleted by centrifugation at 14,000 RPM for 10 
minutes, and 100 µL of supernatant was diluted into 5 mL of ScintiVerse BD Cocktail 
(Fisher Chemical) for counting. All experiments with SynGAP variants were run with GTP 
controls where only GTP-y-32P, but no Rap1b, was present to ensure hydrolysis was Rap1b-
dependent. Relative activity was determined by comparing the amount of GTP hydrolyzed at 
5 or 10 minutes to WT SynGAP variant or free Rap1b (refer to figure legends). 
 HDX-MS of SynGAP truncations; SynGAP-GTPase complexes 
 H/D exchange was initiation by diluting protein samples into deuterium exchange 
buffer (50 mM HEPES, pH 7.5, 150 mM NaCl, 5 mM DTT, 94.9% D2O). Exchange 
reactions were quenched at predetermined time points. by dropping the sample pH to 2.5 
with 200 mM NaH2PO4 (pH 1.7), 4 M GdnHCl and immediately snap freezing in liquid 
nitrogen. Protein samples were converted into uniquely identifiable peptide fragments by 
pepsin digestion. Briefly, frozen H/D samples were quickly thawed and combined with an 
equal volume of an immobilized pepsin slurry (50% v/v washed in 25 mM HEPES, 75 mM 
NaCl, 2.5 mM DTT, 100 mM PO4, 2 M GdnHCl, pH 2.5). The resulting mixture was 
incubated for 3-5 minutes at 4˚C. Immobilized pepsin was removed by brief centrifugation. 
Supernatant was transferred to a fresh Eppendorf tube and snap frozen. Frozen samples were 
stored no longer than one week before MS analysis. 
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 For experiments with the PHC2GAP, C2GAP, and GAP fragments, exchange 
samples were thawed and immediately injected into an Agilent 1260 HPLC equipped with a 
C8 reversed-phase analytical column (Pinnacle DB 5-μm particle, 30 mm × 1 mm, Restek) 
and eluted into a Q-Exactive Orbitrap (Thermo) mass spectrometer equipped with a HESI-II 
electrospray ionization source (Thermo). All columns and tubing were maintained at 0-4 ˚C 
and preequilibrated with cold 0.1% formic acid/10% acetonitrile. Peptides were eluted using 
a gradient elution from 10% to 55% acetonitrile. HDX-MS data were processed and analyzed 
using HDX Workbench [25]. 
 For experiments on the SynGAP-Rap complexes protein samples contained a mixture 
of SynGAP (PHC2GAP or C2GAP) in the presence of a 10-fold excess of Rap1b, or vice-
versa. Deuterium exchange and pepsin digestion was performed as above. Exchanged 
samples were thawed and immediately injected into an ACQUITY UPLC (Waters) equipped 
with a trap column (VanGuard BEH C18, 1.7 µm, 2.1 × 5mm) and an analytical C18 column 
(Waters BEH C18, 130 Å, 1.7 µm, 1 ×100 mm) in line with a SYNAPT G2-Si (Waters) mass 
spectrometer. Peptides were eluted with a gradient of 10% to 55% acetonitrile. Peptides were 
identified using Protein Lynx Global Server (Waters) and HDX-MS data were process and 
analyzed using DynamX (Waters). 
SAXS of SynGAP constructs 
 PHC2GAP and C2GAP samples were purified as described above with one 
modification. After the subtractive Ni-NTA column, enriched protein was further purified 
over a HiLoad 26/600 Superdex 200 (GE Healthcare) column.  A concentration range from 
0.8 – 5 mg/mL were prepared in buffers of 20 mM HEPES, 100-300 mM KCl, 0-5% glycerol 
(pH 7.5) and transferred to 96-well PCR plates (Corning Axygen). The plates were capped 
with a silicone lid (Corning Axygen), sandwiched between two -20 ˚C ice block, and shipped 
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to the Advanced Light Source (ALS) SIBYLS beam link (12.3.1) at Lawrence Berkeley Lab 
for data collection by beamline staff. Each sample was irradiated in 0.3 s burst for a total of 
10 s. Buffer subtraction, data processing, and initial analysis was done with ScÅtter 3.0 
(www.bioisis.net/scatter) software. Ab initio modelling of PHC2GAP and C2GAP domain 
architecture was achieved using GASBOR [26] and visualized using PyMOL. 
 
Results 
The PH and C2 domains allosterically modulate RasGAP domain structural dynamics 
SynGAP requires its C2 domain to stimulate Rap GTPase activity [22]. However, the 
mechanism by which the C2 domain enables the RasGAP domain (from here on called 
simply the GAP domain) to recognize Rap as a substrate remains unclear. One hypothesis is 
that the auxiliary PH and C2 domains have an allosteric effect on the GAP domain. To test 
this hypothesis, we employed HDX-MS to determine if the PH and C2 domains influence the 
conformational dynamics of the GAP domain. Three N-terminal domain truncation variants 
were constructed containing either all three domains (PHC2GAP), the C2 and GAP domains 
(C2GAP), or just the GAP domain (Figure 1A). We first tested the RapGAP activity of each 
construct. Both PHC2GAP and C2GAP stimulated Rap1b GTPase activity, but the GAP 
domain alone did not (Figure 1b). Thus, we suspected the PH domain may have a subtle 
influence C2GAP structural dynamics. 
In parallel, all three variants were diluted into a deuterated buffer and the exchange 
reaction was quenched at predetermined time points to generate H/D exchange rate curves. A 
summary of the results shows that the auxiliary domains induce H/D exchange rate 
perturbations at the GAP domain (Figure 2A). Comparing the C2GAP variant to the GAP 
domain alone reveals a large decrease in H/D exchange at a helical element formed by the C-
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terminus at the C2-GAP domain boundary (Figure 2B). Peptides containing residues 418-436 
and 454-469 show a notable increase in conformational dynamics. Residues 418-436 forms a 
helix-turn-helix positioned between the C2-GAP domain boundary and the catalytic “palm” 
of the GAP domain containing the catalytic residue R470.These perturbations near the 
putative catalytic site suggest allosteric communication between the C2 and GAP domains.  
 The dominant isoforms of SynGAP contain a putative PH domain [27,28]. Under the 
conditions of our activity assay, the PH domain exerted no notable effect on RapGAP 
activity (Figure 1B). Hence, we may surmise the PH domain exerts no allosteric effect on the 
GAP domain. To test this hypothesis, we extended our HDX-MS studies to include a 
comparison of the PHC2GAP and C2GAP SynGAP truncations (Figure 2B). The helical 
element at the C2-GAP boundary is further stabilized as an effect of the PH domain. 
Moderate perturbations were also observed in the C2 domain indicating a slight shift in C2 
structural dynamics. No additional perturbations were observed around the catalytic region of 
the GAP domain, suggesting the influence of the PH domain on RapGAP activity is mediated 
via the C2 domain. 
 
PHC2GAP portion of SynGAP favors linear conformation 
 Having demonstrated the C2 domain influences conformational dynamics of the GAP 
domain in SynGAP, we wanted to address how likely it was the H/D exchange perturbations 
observed were due to allosteric effects or distant domains coming into contact. HDX-MS is 
used in conjunction with structural techniques such as cryo-EM, SAXS, and crystallography 
to aid in interpretation of exchange rate differences [29–32]. From the crystal structure of 
C2GAP, it was proposed the C2 domain occupies the space near the putative Rap1b binding 
site [22]. However, the C2 domain was poorly resolved in this structure leaving the 
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orientation of the C2 domain relative to the GAP domain unclear. Therefore, we employed 
SAXS to outline the domain topology of SynGAP to better understand the spatial 
relationship among the PH, C2, and GAP domains. SAXS is a structural technique useful for 
developing medium resolution models of protein domain topology [33]. Scattering curves 
were collected for various concentrations of the PHC2GAP and C2GAP constructs. We 
elected to use GASBOR to construct ab initio models of SynGAP architecture from 
PHC2GAP and C2GAP scattering curves [26]. The general shape of the PHC2GAP and 
C2GAP structure is an asymmetric, bi-lobed envelope (Figure 3). The larger lobe in both 
envelopes likely correlates to the GAP domain as the GAP domain is three times the size of 
the individual PH or C2 domains. The smaller lobe then represents the C2 domain and the 
PH domain. From the PHC2GAP GASBOR models we conclude the average solution 
conformation of PHC2GAP favors an extended shape. 
 
SynGAP-Rap interactions influence PH and C2 domain conformational dynamics 
 We next sought to investigate the structural dynamics of the SynGAP–Rap complex. 
The interaction between SynGAP and Rap is evidently weak [18], with an estimated Kd in 
the millimolar range. Attempts in our own laboratory to measure an interaction by isothermal 
titration calorimetry, pull down, or circular dichroism yielded no measurable dissociation 
constant (data not shown). HDX-MS is a sensitive technique capable of investigating 
structural perturbations in low affinity protein–protein interaction [35,36]. Therefore, we 
employed HDX-MS to investigate structural perturbations in PHC2GAP and C2GAP 
induced by interactions with Rap1b. 
 The interaction between SynGAP and Rap manifested perturbations in the GAP 
domain for both PHC2GAP and C2GAP (Figure 4). Rap1b induces small H/D exchange rate 
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perturbations for both PHC2GAP and C2GAP variants centered around the surface near 
R470, which makes up the putative Rap1b binding site. Mild perturbations were also 
identified in the C2 and PH domains. In the C2GAP-Rap1b experiment we observed 
perturbations in the C2 domain localized to a single, large peptide containing a poly-glycine 
region (Figure 4A). Removing most of the poly-glycine loop had no apparent effect on 
RapGAP activity [22] (data not shown). We speculate the residues surrounding the poly-G 
region are responsive to Rap1b binding, not the poly-glycine itself.  For the PHC2GAP-
Rap1b interface the coverage in the C2 domain was poor across three replicates, preventing 
any comparison of effects on the C2 domain between constructs (Figure 4B). However, we 
did observe Rap1b-induced exchange rate decreases at residues 160-182 in the PH domain. 
Together, these data demonstrate that conformational dynamics of the PH, C2, and GAP 
domain are affected by Rap1b interaction. 
 
PH and C2 mutants disrupt RapGAP activity 
Our HDX-MS study of the SynGAP-Rap1b complex indicate the PH and C2domain 
structural dynamics are sensitive to the presence of Rap1b. However, it remains unclear if 
these effects are due to allosteric communication with the GAP domain, or distant surfaces of 
the PH or C2 domain contacting the Rap1b substrate. We reasoned that if PH–Rap or C2–
Rap contacts are key for RapGAP function, we could impair RapGAP activity by disrupting 
putative interacting surfaces in the PH and C2 domain. HDX-MS is blind to side chain 
dynamics, which tend to mediate protein–protein interactions. ConSurf is a bioinformatics 
tool used to predict functional residues on the basis of sequence conservation across species 
and predicted solvent exposure [37–39]. A panel of mutants was designed to interrupt 
potential PH-Rap1b or C2-Rap1b interactions based on conservation across mammals and 
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surface exposure, as predicted by ConSURF. Well-conserved and solvent exposed residues 
were selected to test for substrate interactions.  
In the PH domain, mutating residues E179, E182, S196, S197, and E202 resulted in a 
loss of RapGAP function (figure 5A). Less severe loss of function (retaining more than 50% 
activity) was caused by mutating residues R157, E187, D188, K192, and S211. Mutations at 
K239, R244, and N300 in the C2 domain also resulted in a loss of function for the 
PHC2GAP variant. Curiously R155, S285, and T354 yield a more active PHC2GAP variant. 
We note several RapGAP impairing mutants occur in clusters (e.g., S196, S197, E202), 
identifying functional regions not detected by HDX-MS. A few of these mutants overlap with 
perturbed regions from the PH/C2GAP-Rap1b HDX-MS studies (Figure 4B). Taken 
together, these data indicate RapGAP activity can be disrupted by mutating presumably 
distant residues in the PH and C2 domains. 
 
PHC2GAP drives rearrangement of Rap1b GTP-binding regions 
 Having demonstrated that Rap1b has a subtle effect on SynGAP structural dynamics, 
we next considered the structural effect SynGAP has on Rap1b. Crystallographic evidence of 
Rap1b suggest rearrangement of the switch II region drives GTP hydrolysis [40]. Mutating 
key residues in the switch II region impaired the ability of dual-specificity GAPs to stimulate 
Rap GTPase activity [24]. We probed the influence of SynGAP on Rap1b structural 
dynamics using HDX-MS. Rap1b-GPP(C)P (a non-hydrolyzable GTP analogue) in the 
presence of excess PHC2GAP manifests disorder in regions related to GTP binding and H/D 
exchange decreases in the switch I region (Figure 5). Incubating C2GAP with Rap1b-GDP 
manifested H/D exchange decreases primarily in key GTP-binding regions (Figure 5, S1).  
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Together these results indicate SynGAP drives Rap GTPase activity by inducing a 
conformational change in the nucleotide binding pocket. 
 
Discussion 
Auxiliary domains for dual-specificity GAPs are required for RasGAP related 
domains to recognize non-Ras substrates. We built a model of the SynGAP solution structure 
using SAXS that suggests the average conformation is an elongated arrangement of the PH, 
C2, and GAP domains (Figure 3). HDX-MS studies of PHC2GAP, C2GAP, and GAP 
truncations reveal previously unreported allosteric communication from the PH and C2 
domain influence the conformational dynamics of the GAP domain (Figure 2). Furthermore, 
we disrupted RapGAP function with point-mutations in the PH and C2 domain (Figure 4). 
HDX-MS studies of SynGAP-Rap complexes reveals subtle conformational changes induced 
in the PH and C2 domains by Rap1b (Figure 5). From these data, we propose a model where 
the auxiliary domains of SynGAP prime the GAP domain through long-range allostery for 
RapGAP function. Interactions between the GAP domain and Rap1b may induce 
conformational rearrangement of key nucleotide binding regions to stimulate GTPase activity 
(Figure 6).  
Understanding the structural mechanisms of dual-specificity GAPs is key to 
understanding how this family of proteins is able to recognize a diverse range of substrates.  
The requirement of auxiliary PH/C2 domains for RapGAP function is not unique to SynGAP. 
The GAP1m family of proteins contain multiple members with RasGAP domains that also 
recognize Rap as a substrate by virtue of flanking PH or C2 domains. RASAL, CAPRI, and 
GAP1IP4BP contain tandem N-terminal C2 domains which allow the GAP domain to 
recognize Rap1b as a substrate [23,41–43]. For SynGAP and Gap1m proteins that the N-
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terminal C2 domains is thought to be in the vicinity of the Rap1b switch II region [22,24]. 
Because HDX-MS reports on backbone conformational dynamics, we cannot delineate from 
our SynGAP-Rap experiments if HDX perturbations are the result of allostery or contact 
between the C2 domain and Rap. The elongated structure from our SAXS data (figure 3) and 
a recently published cryo-EM model of RASAL domain topology suggest the average C2 
orientation is away from the putative rap docking site [44]. However, the orientation of the 
C2 domain is likely quite flexible [22,44]. It may be the C2 domain samples an extended 
conformer as observed by SAXS and a compact “active” conformation where the C2 domain 
is positioned to aid in RapGAP activity. 
Expanding on this mechanism for RapGAP activity, the GAP domain is responsible 
for contributing the catalytic arginine residue to neutralize the negative charge of the 
phosphates in GTP. Alignment of various RasGAP related domains in a theoretical dual-
specificity GAP-Rap complex was used to identify a conserved helix believed to be key in 
rearranging the switch II region [24]. While we did not observe significant perturbations at 
this helix (corresponding to residues 580-595) as an allosteric effect of the PH/C2 domains 
(figure 2), we did observe ordering of this region in the presence of Rap1b (Figure 4), 
supporting a potentional role for this region in RapGAP activity.  Additionally, our data 
expand on our understanding of RapGAP activity by revealing conformational rearrangement 
of the region containing R470, a potentially key allosteric feature mediated by the auxiliary 
domains. 
Rearrangement of the switch II region in Rap1b positions Q63 to promote GTP 
hydrolysis [40]. Indeed, mutations in this region impair the ability of RASAL and 
Gap1mIP4BP to stimulate Rap GTPase activity [24,43]. Our HDX-MS studies reveal that 
 71 
SynGAP induces disorder around key GTP-binding sites of Rap-GTP, not just the switch II 
region (Figure 6). Once hydrolysis is complete, interactions between SynGAP and Rap-GDP 
result in ordering these regions.  A comprehensive study of small GTPase structural 
dynamics revealed the P-loop of activated Rap-GTP was more dynamic than inactive Rap-
GDP[45]. While we observed no SynGAP-induced perturbation in the P-loop of Rap-
GPP(c)P, we did observe stabilization of this region in Rap-GDP. We conclude that in 
addition to providing a catalytic arginine finger, the GAP domain of SynGAP drives Rap 
GTPase activity by pushing the nucleotide binding pocket conformation toward the inactive 
form. 
We conclude that RapGAP activity for PH/C2GAP is driven by long-range allosteric 
communication between the PH/C2 and GAP domains. In a biological setting, the C-terminal 
tail, which we did not include in our constructs, plays a key role in SynGAP function. 
Phosphorylation in the C-terminal tail modulates SynGAP activity and localization within the 
PSD [18,46–48]. Studying the structural dynamics of SynGAP with this C-terminal addition 
is the next step is fleshing out our understanding of SynGAP biochemistry. Similarly, the 
knowledge gained from this study could also be expanded by applying the same 
methodology to study Gap1m proteins. SynGAP shares many similarities with the GAP1m 
family of proteins [24,41–44]. Perhaps as our understanding of the biochemistry and 
structural biology of dual-specificity GAPs continues to grow we can identify key themes in 
their structure-function relationships.  
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Figures 
 
Figure 1: A) Truncations used to investigate SynGAP N-terminal portion structure-function. 
Green blocks represent regions of potential protein-protein interaction, orange circles are 
phosphorylation sites. Domain start and end positions are numbered as are the N- and C- 
termini. B) RapGAP activity in SynGAP requires PH/C2 domain. Rates were determined by 
fitting a linear regression to a time course of GTP hydrolysis. Dotted lines represent curve fit 
to Michaelis-Menten equation by non-linear least squares method.  
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Figure 2: A) HDX-MS results showing imprint of PH domain on C2 domain of C2GAP. 
Perturbations are net effects of PH and C2 domains. B) HDX-MS results mapped onto GAP 
domain structure (PDB: 3BXJ). Colors indicate H/D exchange rate difference as a result of 
the PH/C2 domain. Color code corresponds to bar at the bottom of the figure. 
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Figure 3: SAXS analysis of C2GAP (red) and PHC2GAP (blue) solution conformations. 
C2GAP and PHC2GAP were diluted into 50 mM HEPES (pH 7.5), 50-300 µM KCl, and 0-
5% glycerol. 28 Frames of data each were collected for three concentrations of protein in six 
buffer conditions. Data with obvious degradation or aggregation were discarded. Remaining 
data were averaged to product representative scattering curves. Solution structure models 
were built using GASBOR. Model robustness was tested by sampling individual frames of 
varied concentration and buffer composition to create ensure consistency among individual 
frames and the pooled data. 
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Figure 4: Peptide coverage of A) C2GAP incubated with 10-fold excess Rap1b and B) 
PHC2GAP incubated with 10-fold excess Rap1b. Each bar represents a uniquely identified 
peptide for and is color coded according to the scale bar between each map. ∆% deuterium 
exchange represents the median exchange before maximum observed exchange. Blue 
peptides indicate regions with lower exchange rates in the presence of excess Rap1b. 
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Figure 5: A) GTPase assay measuring Rap1b GAP-activity for various PHC2GAP variants 
relative to WT. PHC2GAP variant (0.5 µM final) was mixed with 32P-GTP-loaded Rap1b 
(100 µM final) and incubated at RT for 10 minutes. GTPase activity was quenched with 500 
µL charcoal solution (see methods) to adsorb free nucleotides and protein. Free 32P was 
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retrieved by centrifuging the charcoal slurry, taking 50 µL of the supernatant, then diluting 
into 5 mL of BD scintillation cocktail.  Relative activity represents ratio of free 32P for 
PHC2GAP variant compared to WT PHC2GAP. Data represent a single time point, not a 
progress curve. Conserved residues were identified using ConSurf [37–39,49]. B) Location 
of PHC2GAP mutants mapped onto primary structure of PH and C2 domain. Mutations are 
denoted by red text. Up arrows indicate higher activity relative to WT, down arrows indicate 
lower activity relative to WT. Sequence beneath blue bars indicate that region was perturbed 
by Rap1b in HDX-MS experiments. 
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Figure 6: Linear cartoon map of HDX perturbations of Rap1b induced by 
PHC2GAP/C2GAP. Top cartoon color codes Switch I, switch II, and hyper variable region 
(HVR) in green. Regions important for GTP binding are colored yellow. Bottom two bars 
denote regions perturbed by C2GAP/PHC2GAP variants. % Deuterium exchange represents 
median deuterium exchange difference observed and is color coded to the scale bar at the 
bottom of the figure. White denotes regions where no peptides covering that region were 
represented. Data are the average of three technical replicates, and at least two biological 
replicates. 
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Figure S1: Peptide coverage map of Rap1b-GPP(C)P H/D exchange perturbations induced by 
SynGAP. Peptide map is from experiment using PHC2GAP. Bars are color coded according 
to the scale bar below based on the median % deuterium exchange difference. 
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Figure S2: Peptide coverage map of Rap1b-GDP H/D exchange perturbations induced by 
SynGAP. Peptide map is from experiment using C2GAP. Bars are color coded according to 
the scale bar below based on the median % deuterium exchange difference. 
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CHAPTER 4.    MEMBRANE ASSOCIATION AND SYNGAP SUBSTRATE 
RECOGNITION 
Introduction 
Small GTPases participate in a multitude of vital signaling pathways for cellular 
homeostasis. Ras family of GTPases are localized to the membrane via lipid modifications 
made to their C-terminal hyper variable region [1–3]. The type of lipid modification varies 
across individual members of the Ras family and is related to their distinct functions. Two 
Ras family GTPase, HRas and Rap1b, are activated shortly after receptors at the membrane 
are engaged by primary messengers [4]. HRas can be modified at up to three C-terminal 
cysteines with farnesyl and palmitoyl moieties [5,6].  Rap1b, on the other hand, contains a 
single lipidation site and a poly-basic region, which assists in membrane localization [1]. 
Although co-localization with signaling effectors is the most salient advantage of lipid 
modifications, Ras and Rap regulators, including SOS and Gap1m, have augmented 
recognition for lipid-anchored GTPases [7–10]. 
Recruitment of GTPase regulators and effectors to the membrane can be achieved by 
docking with integral membrane proteins or  peripheral membrane interactions mediated by 
membrane-binding domains. PH and C2 domains are among the most common membrane-
binding domains, each exhibiting diverse phospholipid binding surfaces [11–13]. 
Mechanisms of membrane interaction are also diverse, ranging from calcium coordination, 
stereospecific phosphoinositide recognition, or constitutive ionic interactions [12,14]. Then 
conditions under which a PH or C2 domain is recruited to the membrane is a large factor in 
the function and biological role of associated signaling domains. 
 Several Ras and Rap effectors are recruited to the membrane via membrane binding 
domains. Rasal and Capri are dual-specificity Ras- and Rap-GTPase Activating proteins 
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(GAPs) that translocate to the membrane (via their C2 domains) in response to oscillations in 
calcium concentration in cells (which are sensed by their PH domain) [15,16]. In fact the 
RasGAP activity of Rasal is contingent on membrane localization through a C2 domain, but 
not its RapGAP activity [17]. Gap1IP4BP, on the other hand, is constitutively localized to the 
membrane via its PH domain, but it does not appear to be required for RasGAP or RapGAP 
activity [18,19]. SynGAP is also a dual-specificity Ras- and RapGAP that contains a putative 
PH and C2 domain N-terminal to its GAP domain [20,21]. SynGAP is found in the post-
synaptic density of neurons and maintained near the membrane by docking to PSD-95 via its 
C-terminus [20,22,23]. The PH and C2 domains may assist in localizing SynGAP near 
membrane. However, in vitro measurements of SynGAP-membrane interactions have not 
been reported. The goal of this work was to reconstitute membrane-anchored HRas and 
Rap1b in vitro with the objective of investigating SynGAP interactions with Ras and Rap in 
something closer to a biological setting. 
 
Methods 
Protein expression and purification 
 PHC2GAP, C2GAP, and GAP were cloned into a pBAD vector with an N-terminal 
His6 (H6) purification tag and a SUMO folding tag. SynGAP constructs were expressed in 
Tuner(DE3) E. coli. Full length HRas and C118S HRas were cloned into a pET21b vector 
with an N-terminal H6 purification tag and a TEV cleavage site. Full length Rap1b and 
C118S/C141S Rap1b were cloned into a pET21b vector with N-terminal H6-SUMO tags. 
Both HRas and Rap1b constructs were transformed into BL21(DE3) cells for expression. 
Briefly, all expression cultures began by inoculating 50 mL Luria broth supplemented 
with antibiotic with a colony of the desired protein product. This culture was grown 
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overnight at 37 ˚C at 200 rpm. Expression cultures were scaled up by diluting the overnight 
growth 1:100 into 1 L Luria broth with antibiotic. Growth of the culture was monitored until 
the OD600 of 0.5 was reached. At this point the expression protocols diverge. For SynGAP 
variants the temperature was decreased to 18 ˚C and protein expression was induced by 
adding 10 % L-arabinose to a final concentration of 0.1 % in culture. SynGAP variant 
expression continued at 18 ˚C for 24 hours before harvesting. HRas and Rap1b expression 
was induce by adding IPTG to 1 mM. HRas or Rap1b cultures incubated at 37 °C for 5 hours 
with shaking before harvesting. All expression cultures were harvested by centrifugation and 
cell pellets were stored at -80 ˚C until purification. 
H6-tagged proteins were purified over Ni-NTA agarose resin. Briefly, cell pellets 
were resuspended in 50 mM Tris (pH 8.0), 150 mM KCl, 15 mM imidazole, 5 mM ß-
mercaptoethanol (BME), 10% glycerol at a ratio of 1.5 mL buffer per 1 g frozen cell pellet. 
Resuspended and thawed cultures were supplemented with 1 mM PMSF and a pinch of 
lysozyme before lysis by sonication. Insoluble portions of cell lysate were removed by 
centrifugation at 20,000 ×g for 1 hour at 4 ˚C. The clarified supernatant was applied to Ni-
NTA resin preequilibrated in 50 mM Tris (pH 8.0), 150 mM KCl, 15 mM imidazole, 5 mM 
BME, 10% glycerol. Immobilized protein was washed in 50 mM Tris (pH 8.0), 250 mM 
KCl, 25 mM imidazole, 5 mM BME, 10 % glycerol until the UV baseline stabilized. H6-
tagged protein was eluted in 50 mM Tris (pH 8.0), 150 mM KCl, 250 mM imidazole, 5 mM 
BME, 10 % glycerol and fractions with high UV absorbance were collected and pooled. H6-
SUMO tag was removed from SynGAP and Rap constructs by adding H6-Ulp1 during a 3-5 
hours dialysis in 50 mM Tris (pH 8.0), 150 mM KCl, 2 mM dithiotrietol (DTT) at 4 °C. H6-
TEV was removed from HRas constructs by adding H6-GFP-TEV protease and dialyzing 
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overnight at 4 °C in 50 mM Tris (pH 8.0), 150 mM KCl, 2 mM DTT. Cleaved H6 
purification tags and proteases were removed by applying the dialyzed sample to re-
equilibrated Ni-NTA resin and collecting the flow through. Enriched protein was 
concentrated in Amicon Ultra-15 centrifugal spin columns (10 kDa filter, EMD Millipore) 
and purity was assessed by SDS-PAGE. For C118S HRas and C118S/C141S Rap1b variants, 
further purification was performed using a 16/300 HiLoad Superdex 75 column (GE 
Healthcare). 
Preparation of liposomes 
 Liposomes were prepared through the extrusion method. 1-palmitoyl-2-oleoyl-
glycero-3-phophocholine (POPC), 1-palmitoyl-2-oleoyl-glycero-3-phopho-L-serine (POPS), 
1-palmitoyl-2-oleoyl-glycero-3-phophoethanolamine (POPE), and cholesterol were 
purchased from Avanti Polar Lipids. Individual phospholipids dissolved in chloroform were 
mixed in a glass test tube to a composition of 40% POPC, 30% POPE, 20% cholesterol, and 
10% POPS, to mimic the composition of the inner leaflet of the plasma membrane [24–27]. 
Chloroform was evaporated in a fume hood under gentle airflow and the resulting film was 
stored under vacuum at room temperature overnight. Lipids were resuspended in aqueous 
buffer of 50 mM HEPES pH 7.4, 150 mM NaCl by warming to 37 °C and vortexing. Large 
multi-lamellar vesicles (MLVs) were created by alternating freezing in liquid nitrogen and 
thawing in 60 °C water for 10 cycles. Uniformly sized liposomes were produced by passing 
MLVs 20 times through a 400 nm filter using an Avanti mini-extruder device. Liposome 
diameter was determined by dynamic light scattering (Figure 1). 
Liposome sedimentation assay 
 Membrane association of proteins was determined by a liposome sedimentation 
assay. Protein (5 µM) was incubated with liposomes (5 mM total lipid concentration) at room 
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temperature for 30 minutes. Liposomes and associated proteins were pelleted by centrifuging 
the mixture at 100,000 ×g for 30 minutes. The supernatant was removed, and the pellet 
resuspended in an equal volume of 50 mM HEPES (pH 7.4), 150 mM NaCl. Equal volumes 
of supernatant and resuspended pellet were resolved and visualized on a 12% SDS-PAGE 
gel.  Densitometry was used to determine the relative amount of protein in the supernatant 
and pellet. 
Synthesis of N-octadecyl maleimide 
 N-octadecylmaleimide (NOM) was synthesized using the Mitsunobu method [28,29] 
(Scheme 1). Prior to synthesis all glassware was washed, dried, and connected to a Schlenk 
line. Water was completely evaporated by heating glassware under vacuum and flushing the 
system with nitrogen gas. Maleimide (1 equiv), triphenyl phosphine (Ph3P, 1 equiv), and 
octadecanol (1 equiv) were added to a round bottom flask against positive N2 pressure and 
dissolved in anhydrous tetrahydrofuran. 1 equivalent of DEAD was carefully added to the 
solution while stirring. The reaction was allowed to progress at room temperature, over night 
under nitrogen. Consumption of maleimide and production evolution were confirmed by 
TLC. Once all of the maleimide was consumed the mixture was dried in a rotovap. It should 
be noted that solvation of the product was quite difficult, even in chloroform, ethylacetate, or 
THF. The product was isolated on a silica column using ethylacetate as the eluent. The 
identity of the product as NOM was confirmed by 13C NMR spectroscopy (13C ∂ 170.84, 
134.29, 36.76, 28.8, 28.7, 22.01, 13.93). 
In vitro coupling of NOM to HRas/Rap1b 
 NOM was remarkably difficult to dissolve even in organic solutions. We found that 
NOM could be dissolved to 2 mg/mL in a solution of 100 mM n-octylglucoside (nOG) by 
warming the solution to 42 °C and sonicating in a bath sonicator until fully dissolved. First, 
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HRas C118S or Rap1b  C118S C141S was fully reduced with DTT by adding 5-fold molar 
excess DTT over protein concentration. Reducing agent was removed by buffer exchange 
using a PD SpinTrap G-25 (GE Healthcare) spin column according to manufacturer’s 
instructions. Dissolved NOM was then added in 10-fold molar excess to reduced protein and 
incubated with constant agitation at 4 °C overnight. nOG concentration was maintained at 50 
mM during coupling steps to ensure nOG micelles were formed (nOG CMC is 25 mM) and 
encourage  Excess detergent was removed using Bio-Beads (Bio-Rad) to prevent disruption 
of liposomes in later steps. The NOM-labelled protein was stored at -80 °C. Membrane 
anchoring was achieved by combining NOM-labelled protein and liposomes in a molar ratio 
of 10:1 (total lipid to protein) in 50 mM HEPES, pH 7.4, 100 mM NaCl, 0.05% nOG. 
Incorporation into liposomes was confirmed by liposome sedimentation assay.  
GTPase assay 
 Small GTPases in solution or liposomes were loaded with GTP--32P by incubating 
on ice in the presence of 12.5 mM EDTA. GTP loading was quenched by adding 25 mM 
MgCl2. 50 nM PHC2GAP was added to 2 µM soluble or liposome-anchored HRas and 
incubated at 25 ˚C for 10 minutes. The reaction was quenched by adding 500 µL of ice-cold 
charcoal solution (7% w/v activated charcoal in 20 mM NaH2PO4, 1 M HCl, 20% ethanol) 
and vortexed to adsorb protein and GTP to charcoal. Charcoal was removed by centrifugation 
at 14,000 ×g for 10 minutes. 50 µL of supernatant was diluted into 5 mL of ScintiVerse BD 
Cocktail (Fisher Chemical) and 32P content was determined by scintillation counting. 
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Results 
SynGAP binds liposomes via its C2 domain 
 SynGAP contains both PH and C2 domains, but it is unknown if these domains 
interaction with lipids. To test if the PH or C2 domain bind lipids, we employed a simple 
liposomes sedimentation assay. Liposomes were prepared to mimic the general composition 
of the cytosolic surface of the membrane. These were incubated with PHC2GAP, C2GAP, 
and GAP fragments and liposome-bound proteins were separated by centrifugation. Both the 
PHC2GAP and C2GAP constructs bound to liposomes, but the GAP domain did not (Figure 
2). The difference between the PHC2GAP and C2GAP were not significant, suggesting the 
C2 domain is the primary membrane-interacting domain.  
In cellular systems, Ras and Rap are anchored to the membrane through lipid 
modifications [4,30]. Membrane anchoring also influences recognition of Ras and Rap by 
effectors [7,17,19]. Therefore, we next aimed to make proteoliposomes containing Ras or 
Rap to emulate membrane anchoring in cells. Current approaches for producing lipid-
anchored small GTPases either require a complex expression and purification scheme or a 
proprietary reagent [7,8,10,31]. We chose to synthesize a small molecule with a lipid moiety 
that could be linked to cysteine residues in Ras/Rap. N-octadecylmaleimide (NOM) we 
synthesized from octadecanol and maleimide using the Mitsonobu method [28,29]. The 
resulting product was a yellow, waxy compound that was confirmed as NOM by 13C NMR. 
Solubility of NOM up to 2 mg/mL was achieved by mixing it with 100 mM n-octylglucoside 
(nOG), heating, and sonicating the compound for several hours. NOM was coupled to Rap1b 
C118S C141S or HRas C118S, variants designed to remove surface cysteines that could 
compete with the targeted CAAX box residue. The resulting lipidated species were combined  
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with liposomes to produce proteoliposomes. Efficiency of coupling and liposome 
incorporation was evaluated by lipid sedimentation assay (Figure 3).  
 
Discussion 
 Approaches to studying interactions of proteins in a membrane are steadily becoming 
more accessible. We demonstrated the C2 domain of SynGAP binds membranes. In the PSD, 
SynGAP is anchored near the membrane by docking to PSD-95 [20,22,23]. Incidentally, not 
all SynGAP isoforms contain a PDZ-binding motif for interacting with PSD-95, but are 
retained in the PSD [32–34]. In cells, it remains unexplored if lipid binding plays a role in 
SynGAP localization or function. Our data demonstrating the capacity for membrane binding 
suggests a potential unexplored factor in SynGAP biology. Current efforts of this project are 
further exploring what drives this interaction and its role in the enzymatic function of 
SynGAP. 
Here we reported use of octadecanol and maleimide as the reactants for Mitsunobu 
coupling, yielding a product with an 18 C alkyl chain N-linked to the maleimide. Lipid 
modifications of small GTPases are variable among the Ras super family and are thought to 
relate to specialization of function [1,35,36]. Octadecanol can be substituted with another 
fatty alcohol to synthesize lipid anchors to account for variations in small GTPase lipidation. 
For example using hexadecanol to mimic palmitoylation in Ras or geranylgeraniol to mimic 
prenylation in Rap. Indeed, the potential to study small GTPases in a membrane with the 
correct lipid anchors would enhance our understanding of the nuances in interactions 
between small GTPases and effectors. With respect to the PSD, we present the potential to 
study the function of SynGAP in the context of membrane-anchored Ras or Rap. 
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Figures 
 
 
Scheme 1: reaction scheme depicting synthesis of N-Octadecyl maleimide from octadecanol 
and maleimide precursors. Ph3P (1 equiv), maleimide (1 equiv), and octadecanol (1.2 equiv) 
were dissolved in double dehydrated THF under N2.DEAD (1 equiv) was added under 
positive pressure with stirring. The reaction proceeded at room temperature under N2 
overnight. 
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Figure 1: Example DLS intensity plot of prepared liposomes. Liposomes composed of 40 % 
POPC, 30 % POPE, 10% POPS, and 20% Cholesterol were prepared by rehydrating a lipid 
pellet in 50 mM HEPES (pH 7.4) 150 mM NaCl and extruding through a 400 nm filter. 
Median liposome radius is 125 nm. 
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Figure 2: PHC2GAP and C2GAP bind liposome mimicking inner membrane composition. 
PHC2GAP, C2GAP, or GAP were mixed with liposomes (marked Lipids +) or just buffer 
(marked Lipids -) and incubated at RT for 30 minutes. Liposomes were pelleted by 
centrifugation in an airfuge at 30 psi for 45 minutes. The supernatant (S) was removed and 
the liposome pellet (P) was resuspended in an equal amount of buffer. Equal amounts were 
run on a 12% SDS-PAGE gel (see gel image) and fraction bound to liposome was 
determined by densitometry. Background sedimentation as detected by lipids – samples was 
subtracted from lipids + sample to determine fraction bound.  
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Figure 3: Hras C118S was coupled with NOM in the presence of 1-4 mM NOM, 50 mM 
nOG at 4 ˚C overnight. Coupled protein was combined with Liposomes (5 mM total lipid 
concentration) and dialyzed against 50 mM HEPES (pH 7.4), 150 mM NaCl, 2 mM DTT at 4 
˚C overnight. Incorportation into liposomes was determined by lipid sedimentation assay.  
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CHAPTER 5.    CONCLUSIONS AND FUTURE DIRECTIONS 
 One of the ambitions of neuroscience has been to understand the molecular 
mechanisms behind learning and memory. Extracting mechanistic details of individual 
protein components is tantamount to informing a molecular concept of neurological function. 
In this dissertation I addressed two such components, the signaling proteins nNOS and 
SynGAP. Both nNOS and SynGAP play critical roles in maintaining synaptic homeostasis 
and regulating neuroplasticity. I set out to understand how the structural dynamics of nNOS 
and SynGAP related to their unique functions in the PSD. In this chapter, I will briefly 
summarize the conclusions of my work and address areas for future research. 
 
nNOS 
 In chapter 2 I showed the reductase and oxygenase domains communicate through an 
allosteric network. CaM binding is important for coordinating conformational changes in 
nNOS. However, HDX-MS studies of nNOS phosphomimetic variants S847D and S1412D 
point toward a model where allosteric effects link the reductase and oxygenase domain even 
in the absence of CaM. Several other aspects of nNOS structure-function stand to benefit 
from an HDX-MS approach. Phosphorylation at S847 is proposed to displace the 
autoinhibitory insert (AI) and release the FMN subdomain for electron transfer [1–3]. 
Similarly, phosphorylation of S1412 is thought to displace the C-terminal tail (CT), 
stimulating nNOS activity [4,5]. Future work investigating the structural dynamics of nNOS 
variants with AI or CT truncations may help discern if the mechanism of action is via 
displacement of these inhibitory elements or an alternative path. Ongoing work in the  
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Underbakke lab is also considering the effect of interactions between nNOS and other 
proteins and potential influencers of nNOS function. 
 
Ongoing SynGAP Work 
SynGAP has been identified as a dual-specificity Ras- and Rap GAP. One strange 
aspect of this work is the lack of RasGAP activity in my SynGAP constructs. HRas was 
purified from multiple constructs to high purity and the base GTPase activity of HRas 
matched reported values. Even more curiously, a competition assay between Rap1b and 
excess HRas yielded no notable difference in Rap1b stimulation by PHC2GAP. Although 
SynGAP is not the most efficient RasGAP, its role in Ras signaling is supported in the 
literature [6–9]. While other RasGAPs are found in the PSD, none are in such high 
abundance as SynGAP [10]. Although a some reports suggests SynGAP acts through Rap 
signaling, not Ras [11,12]. However, as a putative dual-specificity GAP regulating the Rap 
and Ras pathways are not mutually exclusive. If we do not doubt the RasGAP function of 
SynGAP, why did we not observe RasGAP activity? 
 This missing RasGAP function may relate to the missing C-terminal tail in our 
SynGAP constructs. Phosphorylation in the C-terminal region alters relative RasGAP and 
RapGAP activity of SynGAP in vitro [13,14]. The C-terminal tail was not identified as a 
determinant of enzymatic function, but those studies indicate it informs enzymatic activity. It 
may be that a portion of the C-terminal tail is indeed necessary for recognition of HRas as a 
substrate, similar to how the N-terminal auxiliary domains enable RapGAP activity. 
Currently, the lab is working on constructs with C-terminal extensions beyond the GAP 
domain with the future goal of testing the hypothesis that part of the C-terminal tail is 
required for RasGAP activity.  
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 Another possible explanation for why we did not observe RasGAP activity is that we 
used full-length HRas. Typically the CAAX box and hypervariable region of Ras is not 
include for in vitro assays for ease of use [15]. This was part of the motivation to study the 
role of membrane anchoring in Ras and Rap recognition by PHC2GAP. Membrane 
anchoring is an important determinant of Ras recognition by regulators and effectors [16–
18]. However, we still did not observe stimulation of membrane-anchored HRas by 
PHC2GAP. Leading us to consider the C-terminal tail as a promising candidate for restoring 
RasGAP activity.  
 
Emerging Trends in Dual-Specificity GAP Structural Biology? 
 Much of our understanding of dual-specificity GAPs stems from efforts focusing on 
the Gap1m family. The domain arrangement and function of the Gap1m family is similar to 
SynGAP, leading to a long-standing reciprocal relationship in SynGAP and Gap1m research. 
Gap1m proteins have a tandem C2 domain N-terminal to the RasGAP domain, and a PH/Btk-
homology domain C-terminal to the GAP domain. The tandem C2 domains of Gap1m 
proteins enable RapGAP activity, similar to the C2 domain of SynGAP [19,20]. The 
requirement for an catalytic arginine for RapGAP activity, rather than asparagine, is also a 
shared feature of SynGAP and Gap1m proteins [21,22]. In light of my work on SynGAP 
structural dynamics as revealed by HDX-MS, it may be allosteric communication may also 
play in role in activating the Gap1m RasGAP domains. Indeed, one of the future aspirations 
for this work is to determine how the structural dynamics of other dual-specificity GAPs are 
informed by their auxiliary domains.  
Including this work, structural studies of dual-specificity GAPs are limited 
[20,21,23]. An understanding of enzyme structure is a large factor in understanding the 
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mechanisms of enzyme function. The largest model of dual-specificity GAP domain 
architecture comes from a cryo-EM model of Rasal [23]. Rasal domain topology can be 
crudely described as a “bunny ear” architecture, where the tandem C2 domains and the 
PH/Btk homology domain extend from the N- and C-terminus of the GAP domain, 
respectively, and meet at the helical element (discussed for SynGAP in Chapter 3) in the 
GAP domain. Based on my SAXS model, the silhouette of PHC2GAP forms an elongated 
structure similar to the tandem C2-GAP portion of RASAL (Figure 1). While more structural 
information is needed, a general model of dual-specificity GAP structure may serve as a 
useful reference for dissecting the unique functions of individual Gap1m or SynGAP family 
proteins.  
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Figures 
 
Figure 1: Cartoon model of potential dual-specificity GAP (Gap1m and SynGAP families) 
domain architecture. Relative domain organization is based on cryo-EM data of Rasal [23] 
and SAXS data for PHC2GAP presented in chapter 3. Domain labels are for Rasal, with 
corresponding SynGAP domains in parentheses when they differ. 
 
